@NP	- and fast-twitch rat hind limb skeletal muscle phenotypes	5
@NP	fast-twitch rat hind limb skeletal muscle	11
@NP	fast-twitch rat hind limb	11
@NP	8 months	64
@NP	spinal cord transection	78
@NP	olfactory ensheathing glia transplantation Pilar Negredo1 , Jos ' e-Luis L.	106
@NP	olfactory ensheathing glia transplantation Pilar Negredo1	106
@NP	Jos ' e-Luis L.	166
@NP	Jos '	166
@NP	Olfactory ensheathing glia -LRB- OEG -RRB- transplants	812
@NP	Olfactory ensheathing glia	812
@NP	OEG	840
@NP	axonal regeneration	887
@NP	sensory-motor function	922
@NP	animals with SCI	948
@NP	animals	948
@NP	SCI	961
@NP	We	966
@NP	OEG transplants	987
@NP	skeletal muscle phenotypic deterioration	1019
@NP	this effect	1069
@NP	the functional recovery observed in behavioural tests	1096
@NP	the functional recovery	1096
@NP	behavioural tests	1132
@NP	A variety of morphological , metabolic and molecular markers	1151
@NP	A variety	1151
@NP	morphological , metabolic and molecular markers	1164
@NP	soleus -LRB- SOL -RRB- and extensor digitorum longus -LRB- EDL -RRB-	1228
@NP	soleus	1228
@NP	SOL	1236
@NP	extensor digitorum longus	1245
@NP	EDL	1272
@NP	muscles	1277
@NP	spinal cord transected -LRB- SCT -RRB-	1288
@NP	spinal cord	1288
@NP	SCT	1312
@NP	OEG-transplanted rats	1318
@NP	8 months	1340
@NP	the intervention	1354
@NP	non-transplanted SCT rats	1389
@NP	sham-operated -LRB- without SCT -RRB- controls -LRB- C -RRB-	1419
@NP	sham-operated -LRB- without SCT -RRB- controls	1419
@NP	SCT	1442
@NP	C	1457
@NP	A multivariate analysis encompassing all the parameters	1461
@NP	A multivariate analysis	1461
@NP	all the parameters	1498
@NP	OEG-transplanted rats	1532
@NP	skeletal muscle phenotypes	1564
@NP	non-transplanted and sham-operated controls	1612
@NP	both	1676
@NP	A high correlation	1682
@NP	sensory-motor functional capacity	1743
@NP	expression level of slow	1781
@NP	expression level	1781
@NP	fast-twitch hind limb skeletal muscle	1811
@NP	fast-twitch hind limb	1811
@NP	skeletal muscle	1833
@NP	particularly the histochemical glycerol-3-phosphate dehydrogenase activity	1869
@NP	− 0.843 , P < 0.0001	1945
@NP	− 0.843	1945
@NP	P < 0.0001	1953
@NP	P	1953
@NP	0.0001	1956
@NP	the fraction of variant 2s of the slow regulatory myosin light chain isoform	1968
@NP	the fraction	1968
@NP	variant 2s of the slow regulatory myosin light chain isoform	1984
@NP	variant 2s	1984
@NP	the slow regulatory myosin light chain isoform	1998
@NP	0.848 , P < 0.0001	2046
@NP	0.848	2046
@NP	P < 0.0001	2053
@NP	P	2053
@NP	0.0001	2056
@NP	SOL	2067
@NP	the mean overall effect	2080
@NP	OEG transplants	2107
@NP	patterning skeletalmuscle protein expression towards normal , in 6 out	2126
@NP	patterning skeletalmuscle protein expression	2126
@NP	normal	2179
@NP	6	2190
@NP	9 animals	2199
@NP	they	2209
@NP	fibre type switching	2248
@NP	a consistent	2284
@NP	long-term maintenance of normal skeletal muscle characteristics	2313
@NP	long-term maintenance	2313
@NP	normal skeletal muscle characteristics	2338
@NP	The interplay of OEG and exercise-mediated neurotrophic actions	2378
@NP	The interplay	2378
@NP	OEG and exercise-mediated neurotrophic actions	2395
@NP	a plausible mechanism	2445
@NP	OEG transplantation effects	2478
@NP	skeletal muscle	2519
@NP	Complete spinal cord injury -LRB- SCI -RRB-	2537
@NP	Complete spinal cord injury	2537
@NP	SCI	2566
@NP	long spinal pathways and disconnects	2580
@NP	long spinal pathways	2580
@NP	disconnects	2605
@NP	organs	2624
@NP	the brain	2636
@NP	failure	2654
@NP	neurons to regenerate their axons spontaneously in the mature CNS milieu	2665
@NP	their axons	2687
@NP	the mature CNS milieu	2716
@NP	SCI	2739
@NP	disabling	2747
@NP	permanent effects	2758
@NP	loss of voluntary movement	2789
@NP	loss	2789
@NP	voluntary movement	2797
@NP	appearance of involuntary muscle spasms	2817
@NP	appearance	2817
@NP	involuntary muscle spasms	2831
@NP	loss of somatosensory function	2861
@NP	loss	2861
@NP	somatosensory function	2869
@NP	the injury site	2898
@NP	skeletal muscle experiences	2925
@NP	progressive atrophy	2953
@NP	reduced fibre cross-sectional area	2978
@NP	alterations	3030
@NP	contractile and metabolic properties	3045
@NP	a switch in gene expression programs	3097
@NP	a switch	3097
@NP	gene expression programs	3109
@NP	those governing the isoforms of the myosin subunits	3148
@NP	those	3148
@NP	the isoforms of the myosin subunits	3164
@NP	the isoforms	3164
@NP	the myosin subunits	3180
@NP	Schiaffino & Reggiani , 1996	3205
@NP	Schiaffino & Reggiani	3205
@NP	1996	3228
@NP	Pette & Staron , 1997	3234
@NP	Pette & Staron	3234
@NP	1997	3250
@NP	Talmadge , 2000	3256
@NP	Talmadge	3256
@NP	2000	3266
@NP	Pette & Staron , 2001	3272
@NP	Pette & Staron	3272
@NP	2001	3288
@NP	review	3297
@NP	rodentswith a complete spinal cord transection -LRB- SCT -RRB-	3309
@NP	rodentswith a complete spinal cord transection	3309
@NP	rodentswith	3309
@NP	a complete spinal cord transection	3321
@NP	SCT	3357
@NP	the slow-twitch SOLmuscle	3363
@NP	a dramatic reduction	3401
@NP	the proportion	3425
@NP	the slow myosin heavy chain -LRB- MHC -RRB- isoform -LRB- MHC-I or β/slow -RRB-	3443
@NP	the slow myosin heavy chain -LRB- MHC -RRB- isoform	3443
@NP	slow myosin heavy chain -LRB- MHC -RRB-	3447
@NP	slow myosin heavy chain	3447
@NP	MHC	3472
@NP	MHC-I or β/slow	3486
@NP	MHC-I	3486
@NP	β/slow	3495
@NP	the major isoform of this muscle accounting	3504
@NP	the major isoform	3504
@NP	this muscle accounting	3525
@NP	90 % of the MHC content	3558
@NP	90 %	3558
@NP	the MHC content	3565
@NP	The reduced proportion of MHC-I	3582
@NP	The reduced proportion	3582
@NP	MHC-I	3608
@NP	increases in the fast MHC isoforms IIa	3632
@NP	increases	3632
@NP	the fast MHC isoforms IIa	3645
@NP	IIx/d	3675
@NP	a limited extent	3689
@NP	IIb -LRB- Talmadge et al. 1995 , 1999 -RRB-	3712
@NP	IIb	3712
@NP	Talmadge	3717
@NP	et al. 1995 , 1999	3726
@NP	et al.	3726
@NP	1995	3733
@NP	1999	3739
@NP	These transitions in the MHC expression pattern	3746
@NP	These transitions	3746
@NP	the MHC expression pattern	3767
@NP	increases	3813
@NP	the maximal speed	3826
@NP	agreement	3862
@NP	the established correlation	3877
@NP	the MHC isoform	3913
@NP	a fibre	3942
@NP	its maximal velocity	3954
@NP	contraction	3978
@NP	Reiser	3991
@NP	et al. 1985 ; Sweeney et al. 1986 ; Bottinelli et al. 1991	3998
@NP	et al. 1985 ; Sweeney et al. 1986 ; Bottinelli et al.	3998
@NP	et al. 1985	3998
@NP	et al.	3998
@NP	1985	4005
@NP	Sweeney et al. 1986	4011
@NP	Sweeney	4011
@NP	et al.	4019
@NP	1986	4026
@NP	Bottinelli et al.	4032
@NP	Bottinelli	4032
@NP	et al.	4043
@NP	1991	4050
@NP	A shift of intermediary metabolism towards more glycolytic phenotypes	4057
@NP	A shift	4057
@NP	intermediary metabolism towards more glycolytic phenotypes	4068
@NP	intermediary metabolism	4068
@NP	more glycolytic phenotypes	4100
@NP	Talmadge , 2000 ; Otis et al. 2004	4150
@NP	Talmadge , 2000 ; Otis et al.	4150
@NP	Talmadge , 2000	4150
@NP	Talmadge	4150
@NP	2000	4160
@NP	Otis et al.	4166
@NP	Otis	4166
@NP	et al.	4171
@NP	2004	4178
@NP	Soleus muscle of SCT rats	4185
@NP	Soleus muscle	4185
@NP	SCT rats	4202
@NP	a relatively high proportion of hybrid fibres	4237
@NP	a relatively high proportion	4237
@NP	hybrid fibres	4269
@NP	two or more different MHC isoforms -LRB- Talmadge et al. 1999 -RRB-	4297
@NP	two or more different MHC isoforms	4297
@NP	Talmadge	4333
@NP	et al. 1999	4342
@NP	et al.	4342
@NP	1999	4349
@NP	The persistence of hybrid fibres	4356
@NP	The persistence	4356
@NP	hybrid fibres	4375
@NP	an indication	4401
@NP	it	4420
@NP	a stable phenotypic characteristic	4434
@NP	skeletal muscle -LRB- Talmadge , 2000 -RRB-	4482
@NP	skeletal muscle	4482
@NP	Talmadge , 2000	4499
@NP	Talmadge	4499
@NP	2000	4509
@NP	Myosin light chains -LRB- MLCs -RRB-	4516
@NP	Myosin light chains	4516
@NP	MLCs	4537
@NP	the contractile velocity of fibres	4574
@NP	the contractile velocity	4574
@NP	fibres	4602
@NP	a specified range for each MHC isoform -LRB- Bottinelli et al. 1994 -RRB-	4616
@NP	a specified range	4616
@NP	each MHC isoform -LRB- Bottinelli et al. 1994 -RRB-	4638
@NP	each MHC isoform	4638
@NP	Bottinelli	4655
@NP	et al. 1994	4666
@NP	et al.	4666
@NP	1994	4673
@NP	The isoform transitions	4680
@NP	essential -LRB- eMLCs -RRB- and regulatory -LRB- rMLCs -RRB-	4707
@NP	essential -LRB- eMLCs -RRB-	4707
@NP	regulatory -LRB- rMLCs -RRB-	4729
@NP	MLCs	4748
@NP	rat skeletal muscle	4765
@NP	SCI -LRB- Lee & Braun , 1990 -RRB-	4795
@NP	SCI	4795
@NP	Lee & Braun	4800
@NP	1990	4813
@NP	skeletal muscle contractile properties	4850
@NP	reduced neuromuscular activity , leading to faster	4892
@NP	reduced neuromuscular activity	4892
@NP	more fatigable phenotypes	4943
@NP	Several studies	4970
@NP	interventions	5002
@NP	the neuromuscular activity	5027
@NP	the level of electrical activation or the load bearing , or both ,	5075
@NP	the level	5075
@NP	electrical activation or the load bearing , or both ,	5088
@NP	electrical activation or the load bearing	5088
@NP	electrical activation	5088
@NP	the load bearing	5113
@NP	both	5134
@NP	transitions of MHC expression in the fast-to-slow direction , i.e.	5150
@NP	transitions	5150
@NP	MHC expression in the fast-to-slow direction	5165
@NP	MHC expression	5165
@NP	the fast-to-slow direction	5183
@NP	the effect of SCI	5225
@NP	the effect	5225
@NP	SCI	5239
@NP	These transitions	5244
@NP	an ordered sequence -LRB- MHC-IIb > MHC-IIx/d > MHC-IIa > MHC-I -RRB-	5269
@NP	an ordered sequence	5269
@NP	MHC-IIb > MHC-IIx/d > MHC-IIa > MHC-I	5290
@NP	MHC-IIb	5290
@NP	> MHC-IIx/d > MHC-IIa > MHC-I	5297
@NP	> MHC-IIx/d	5297
@NP	> MHC-IIa	5307
@NP	> MHC-I	5315
@NP	phenotypic changes	5342
@NP	skeletal muscle as	5364
@NP	the theory	5395
@NP	the continuum of MHC isoformexpression -LRB- Staron & Pette , 1993 -RRB-	5409
@NP	the continuum	5409
@NP	MHC isoformexpression -LRB- Staron & Pette , 1993 -RRB-	5426
@NP	MHC isoformexpression	5426
@NP	Staron & Pette	5449
@NP	1993	5463
@NP	Low-frequency electrical stimulation	5470
@NP	resistance or endurance exercise training	5532
@NP	resistance	5532
@NP	endurance exercise training	5546
@NP	the expression	5626
@NP	MHCs	5644
@NP	slower isoforms -LRB- Talmadge , 2000 ; Baldwin & Haddad , 2001 -RRB-	5656
@NP	slower isoforms	5656
@NP	Talmadge , 2000 ; Baldwin & Haddad , 2001	5673
@NP	Talmadge	5673
@NP	2000 ; Baldwin & Haddad	5683
@NP	2000	5683
@NP	Baldwin & Haddad	5689
@NP	2001	5707
@NP	addition to interventions that increase neuromuscular activity	5717
@NP	addition	5717
@NP	interventions that increase neuromuscular activity	5729
@NP	interventions	5729
@NP	neuromuscular activity	5757
@NP	a switch of MHC isoform expression in the fast-to-slow direction	5781
@NP	a switch	5781
@NP	MHC isoform expression in the fast-to-slow direction	5793
@NP	MHC isoform expression	5793
@NP	the fast-to-slow direction	5819
@NP	rat	5872
@NP	SOL and EDL muscles	5876
@NP	conditions	5902
@NP	hypothyroidism , glucocorticoid treatment , diabetes and ageing	5916
@NP	hypothyroidism	5916
@NP	glucocorticoid treatment	5932
@NP	diabetes	5958
@NP	ageing	5971
@NP	Pette & Staron , 1997 for a review	5983
@NP	Pette & Staron	5983
@NP	1997 for a review	5999
@NP	1997	5999
@NP	a review	6008
@NP	no known treatment	6030
@NP	functional regeneration	6073
@NP	a complete spinal cord transection in humans	6104
@NP	a complete spinal cord transection	6104
@NP	humans	6142
@NP	Paraplegic patients	6150
@NP	temporal activation of target organs	6180
@NP	temporal activation	6180
@NP	target organs	6203
@NP	means	6220
@NP	electrical stimulation	6229
@NP	motor rehabilitation and improvement	6256
@NP	bladder and bowel function -LRB- Prochazka & Mushahwar , 2001 -RRB-	6296
@NP	bladder and bowel function	6296
@NP	Prochazka & Mushahwar	6324
@NP	2001	6347
@NP	Passive exercise and arm cranking	6354
@NP	Passive exercise	6354
@NP	arm cranking	6375
@NP	a palliative treatment	6411
@NP	motor automatism	6443
@NP	Wernig et al. 1999 ; Kjaer , 2000	6487
@NP	Wernig	6487
@NP	et al. 1999 ; Kjaer , 2000	6494
@NP	et al. 1999	6494
@NP	et al.	6494
@NP	1999	6501
@NP	Kjaer , 2000	6507
@NP	Kjaer	6507
@NP	2000	6514
@NP	These palliative strategies	6521
@NP	consistentwith experimental observations	6553
@NP	exercise or muscle activity induced by electrical stimulation	6610
@NP	exercise or muscle activity	6610
@NP	electrical stimulation	6649
@NP	changes	6697
@NP	skeletal muscle properties induced by SCI	6708
@NP	skeletal muscle properties	6708
@NP	SCI	6746
@NP	Dupont-Versteegden	6751
@NP	et al. 1998 ; Hartkopp et al. 2003 ; Shields & Dudley-Javoroski , 2006	6770
@NP	et al. 1998	6770
@NP	et al.	6770
@NP	1998	6777
@NP	Hartkopp et al. 2003	6783
@NP	Hartkopp	6783
@NP	et al.	6792
@NP	2003	6799
@NP	Shields & Dudley-Javoroski , 2006	6805
@NP	Shields & Dudley-Javoroski	6805
@NP	2006	6833
@NP	the neuromuscular activity	6851
@NP	re-establishment	6899
@NP	upper motor neuron pathways	6941
@NP	SCI individuals	6972
@NP	skeletal muscle protein expression pattern	7002
@NP	muscles	7055
@NP	the experimental approaches	7085
@NP	recent years	7126
@NP	an effective regeneration of the injured spinal cord	7150
@NP	an effective regeneration	7150
@NP	the injured spinal cord	7179
@NP	transplantation of olfactory ensheathing glia -LRB- OEG -RRB-	7204
@NP	transplantation	7204
@NP	olfactory ensheathing glia -LRB- OEG -RRB-	7223
@NP	olfactory ensheathing glia	7223
@NP	OEG	7251
@NP	one	7271
@NP	the most promising strategies	7278
@NP	Ramon-Cueto & Valverde	7309
@NP	1995	7333
@NP	Raisman , 2001	7339
@NP	Raisman	7339
@NP	2001	7348
@NP	Keyvan-Fouladi et al. 2002	7354
@NP	Keyvan-Fouladi	7354
@NP	et al.	7369
@NP	2002	7376
@NP	Wewetzer et al. 2002	7382
@NP	Wewetzer	7382
@NP	et al.	7391
@NP	2002	7398
@NP	Santos-Benito & Ramon-Cueto , 2003	7404
@NP	Santos-Benito & Ramon-Cueto	7404
@NP	2003	7433
@NP	Barnett & Riddell , 2004	7439
@NP	Barnett & Riddell	7439
@NP	2004	7458
@NP	histological data and behavioural tests	7474
@NP	histological data	7474
@NP	behavioural tests	7496
@NP	OEG transplantation	7515
@NP	axonal regeneration	7564
@NP	the rat SC and recovery	7587
@NP	sensory-motor function -LRB- Ramon-Cueto et al. 2000 -RRB-	7614
@NP	sensory-motor function	7614
@NP	Ramon-Cueto et al. 2000	7638
@NP	Ramon-Cueto	7638
@NP	et al. 2000	7650
@NP	et al.	7650
@NP	2000	7657
@NP	this context	7667
@NP	we	7681
@NP	OEG transplantation	7698
@NP	the effect of SCT	7734
@NP	the effect	7734
@NP	SCT	7748
@NP	slow - and fast-twitch rat hind limb skeletal muscle phenotypes	7755
@NP	normal contractile properties	7849
@NP	functional recovery	7893
@NP	the present investigation	7927
@NP	the impact of OEG transplants	7988
@NP	the impact	7988
@NP	OEG transplants	8002
@NP	the phenotypic features	8021
@NP	fast - and slow-twitch hind limb	8048
@NP	skeletal muscles of rats with completely transected spinal cords	8080
@NP	skeletal muscles	8080
@NP	rats with completely	8100
@NP	rats	8100
@NP	spinal cords	8132
@NP	A second aim of this research	8146
@NP	A second aim	8146
@NP	this research	8162
@NP	motor functional capacity	8196
@NP	OEG-transplanted rats	8225
@NP	means	8273
@NP	behavioural tests	8282
@NP	the same animals of this study -LRB- Ramon-Cueto et al. 2000 -RRB-	8304
@NP	the same animals	8304
@NP	this study -LRB- Ramon-Cueto et al. 2000 -RRB-	8324
@NP	this study	8324
@NP	Ramon-Cueto et al. 2000	8336
@NP	Ramon-Cueto	8336
@NP	et al. 2000	8348
@NP	et al.	8348
@NP	2000	8355
@NP	the extent that affected slow -LRB- SOL -RRB-	8378
@NP	the extent	8378
@NP	SOL	8409
@NP	fast-twitch -LRB- EDL -RRB- skeletal muscle approached normal phenotype	8418
@NP	fast-twitch	8418
@NP	EDL	8431
@NP	skeletal muscle	8436
@NP	normal phenotype	8463
@NP	this investigation	8490
@NP	sensitive markers	8536
@NP	skeletal muscle phenotype	8557
@NP	a quantitative basis changes in the locomotor capacity of SCT animals	8617
@NP	a quantitative basis changes	8617
@NP	the locomotor capacity of SCT animals	8649
@NP	the locomotor capacity	8649
@NP	SCT animals	8675
@NP	response	8690
@NP	OEG transplantation	8702
@NP	Methods Preparation	8724
@NP	adult olfactory bulb OEG	8747
@NP	transplantation	8776
@NP	damaged spinal cord Preparation of adult rat olfactory bulb OEG	8797
@NP	damaged spinal cord Preparation	8797
@NP	adult rat olfactory bulb OEG	8832
@NP	a previously described procedure -LRB- Ramon-Cueto & Nieto-Sampedro , 1992 -RRB-	8885
@NP	a previously described procedure	8885
@NP	Ramon-Cueto & Nieto-Sampedro	8919
@NP	1992	8949
@NP	Olfactory bulbs	8956
@NP	adult Wistar Hannover rats -LRB- 2 -- 2.5 months old , Charles River -RRB-	8992
@NP	adult Wistar Hannover rats	8992
@NP	2	9020
@NP	2.5 months old , Charles River	9022
@NP	2.5 months old	9022
@NP	Charles River	9038
@NP	decapitation	9064
@NP	deep ketamine anaesthesia	9083
@NP	Imalgene , Rhone Merieux	9110
@NP	Imalgene	9110
@NP	Rhone Merieux	9120
@NP	Lyon ; 15 mg -LRB- 100 g body weight -RRB- − 1 , i.p.	9135
@NP	Lyon	9135
@NP	15 mg -LRB- 100 g body weight -RRB- − 1 , i.p.	9141
@NP	15 mg -LRB- 100 g body weight -RRB- − 1	9141
@NP	15 mg -LRB- 100 g body weight -RRB-	9141
@NP	15 mg	9141
@NP	100 g body weight	9147
@NP	The olfactory bulbs of one rat per transplanted animal	9176
@NP	The olfactory bulbs	9176
@NP	one rat per transplanted animal	9199
@NP	one rat	9199
@NP	transplanted animal	9211
@NP	the heads	9251
@NP	sterile conditions	9267
@NP	The first two olfactory bulb layers	9287
@NP	inHank 's balanced salt solution	9338
@NP	inHank 's	9338
@NP	calcium and magnesium ions -LRB- HBSS , Gibco -RRB-	9375
@NP	calcium and magnesium ions	9375
@NP	HBSS	9403
@NP	Gibco	9409
@NP	10 min at 37 ◦ C	9434
@NP	10 min	9434
@NP	37 ◦ C	9444
@NP	0.25 % trypsin -LRB- w/v , Sigma -RRB-	9454
@NP	0.25 % trypsin	9454
@NP	w/v	9469
@NP	Sigma	9474
@NP	a sterile tube	9483
@NP	5 ml of HBSS -- EDTA -LRB- without calcium and magnesium , 1 mm EDTA -RRB-	9509
@NP	5 ml	9509
@NP	HBSS -- EDTA -LRB- without calcium and magnesium , 1 mm EDTA -RRB-	9516
@NP	HBSS	9516
@NP	EDTA	9521
@NP	calcium and magnesium , 1 mm EDTA	9535
@NP	calcium and magnesium	9535
@NP	1 mm EDTA	9558
@NP	Treatment with trypsin	9569
@NP	Treatment	9569
@NP	trypsin	9584
@NP	D/F -10 S	9614
@NP	DEMEM and Ham 's F-12 media , 1 : 1	9623
@NP	DEMEM	9623
@NP	Ham 's F-12 media , 1 : 1	9633
@NP	Ham 's F-12 media	9633
@NP	Ham 's	9633
@NP	1 : 1	9651
@NP	Gibco	9658
@NP	10 % fetal bovine serum , 100 Uml − 1 penicillin	9683
@NP	10 % fetal bovine serum	9683
@NP	100 Uml − 1 penicillin	9707
@NP	100 Uml −	9707
@NP	1 penicillin	9715
@NP	100 μgml − 1 streptomycin	9732
@NP	100 μgml −	9732
@NP	1 streptomycin	9741
@NP	several times	9772
@NP	D/F -10 S and centrifuging	9791
@NP	D/F -10 S	9791
@NP	centrifuging	9803
@NP	cells	9817
@NP	1 ml D/F	9843
@NP	-10 S using a fire-polished Pasteur pipette	9850
@NP	-10 S	9850
@NP	a fire-polished Pasteur pipette	9861
@NP	Cells from two olfactory bulbs	9894
@NP	Cells	9894
@NP	two olfactory bulbs	9905
@NP	one poly l-lysine -LRB- 10 000 -- 30 000 MW , Sigma -RRB-	9942
@NP	one poly l-lysine	9942
@NP	10 000 -- 30 000 MW , Sigma	9961
@NP	10 000	9961
@NP	30 000 MW , Sigma	9968
@NP	30 000 MW	9968
@NP	Sigma	9979
@NP	coated culture flask -LRB- 25 cm2 , Falcon -RRB-	9986
@NP	coated culture flask	9986
@NP	25 cm2	10008
@NP	Falcon	10016
@NP	D/F -10 S	10040
@NP	37 ◦ C and 5 % CO2	10051
@NP	37 ◦ C	10051
@NP	5 % CO2	10060
@NP	Culture medium	10068
@NP	every 2 -- 3 days	10095
@NP	every 2	10095
@NP	3 days	10103
@NP	Seven days	10111
@NP	cells	10137
@NP	the flasks using 0.1 % trypsin -LRB- w/v -RRB- in Ca2 +	10162
@NP	the flasks	10162
@NP	0.1 % trypsin -LRB- w/v -RRB- in Ca2	10179
@NP	0.1 % trypsin -LRB- w/v -RRB-	10179
@NP	0.1 % trypsin	10179
@NP	w/v	10193
@NP	Ca2	10201
@NP	+	10204
@NP	Mg2 + - free HBSS medium	10206
@NP	Mg2 +	10206
@NP	Mg2	10206
@NP	+	10209
@NP	free HBSS medium	10211
@NP	P75 receptor-expressing OEG	10229
@NP	immunoaffinity	10274
@NP	an antibody	10295
@NP	p75	10315
@NP	hybridoma 192	10320
@NP	Dr Patrick Wood , Miami Project	10354
@NP	Dr Patrick Wood	10354
@NP	Miami Project	10371
@NP	Paralysis	10393
@NP	Ramon-Cueto	10430
@NP	et al. 1998 , 2000	10442
@NP	et al.	10442
@NP	1998	10449
@NP	2000	10455
@NP	96 mm Petri dishes	10471
@NP	96 mm	10471
@NP	Petri dishes	10476
@NP	anti-mouse IgG -LRB- 1/1000 ; Jackson Immunoresearch -RRB- for 12 h at 4 ◦ C	10520
@NP	anti-mouse IgG -LRB- 1/1000 ; Jackson Immunoresearch -RRB-	10520
@NP	anti-mouse IgG	10520
@NP	1/1000 ; Jackson Immunoresearch	10536
@NP	1/1000	10536
@NP	Jackson Immunoresearch	10544
@NP	12 h at 4 ◦ C	10572
@NP	12 h	10572
@NP	4 ◦ C	10580
@NP	the supernatant of hybridoma 192 -LRB- 1/5 -RRB-	10605
@NP	the supernatant	10605
@NP	hybridoma 192 -LRB- 1/5 -RRB-	10624
@NP	hybridoma 192	10624
@NP	1/5	10639
@NP	mouse anti-p75	10655
@NP	12 h at 4 ◦ C	10680
@NP	12 h	10680
@NP	4 ◦ C	10688
@NP	DMEM	10709
@NP	Cells	10715
@NP	culture flasks	10735
@NP	ontotreatedPetri dishes -LRB- at a ratio of twoflasks per Petri dish -RRB-	10762
@NP	ontotreatedPetri dishes	10762
@NP	a ratio of twoflasks per Petri dish	10790
@NP	a ratio	10790
@NP	twoflasks per Petri dish	10801
@NP	twoflasks	10801
@NP	Petri dish	10815
@NP	Unbound cells	10828
@NP	cells	10864
@NP	the dishes with a cell scraper	10889
@NP	the dishes	10889
@NP	a cell scraper	10905
@NP	poly	10936
@NP	l-lysine-treated 25 cm2 flasks -LRB- two dishes per flask -RRB-	10941
@NP	l-lysine-treated 25 cm2 flasks	10941
@NP	25	10958
@NP	two dishes per flask	10973
@NP	two dishes	10973
@NP	flask	10988
@NP	P75-OEG	10996
@NP	D/F -10 S for no more than 2 weeks	11021
@NP	D/F -10 S	11021
@NP	no more than 2 weeks	11033
@NP	senescence	11063
@NP	Two days	11075
@NP	2 μm forskolin	11098
@NP	Sigma	11114
@NP	20 μgml − 1 bovine pituitary extract -LRB- Biomedical Technologies Inc. -RRB-	11125
@NP	20 μgml −	11125
@NP	1 bovine pituitary extract -LRB- Biomedical Technologies Inc. -RRB-	11133
@NP	1 bovine pituitary extract	11133
@NP	Biomedical Technologies Inc.	11161
@NP	the culture medium	11205
@NP	these components	11229
@NP	the whole culture period	11264
@NP	Medium	11290
@NP	every 2 -- 3 days	11309
@NP	every 2	11309
@NP	3 days	11317
@NP	transplantation	11329
@NP	we	11345
@NP	only p75 immunoreactive OEG , the only OEG capable	11353
@NP	only p75	11353
@NP	immunoreactive OEG	11362
@NP	the only OEG	11382
@NP	axon enfolding -LRB- Ramon-Cueto et al. 1993 -RRB-	11406
@NP	axon enfolding	11406
@NP	Ramon-Cueto et al. 1993	11422
@NP	Ramon-Cueto	11422
@NP	et al. 1993	11434
@NP	et al.	11434
@NP	1993	11441
@NP	transplantation	11460
@NP	cells	11477
@NP	the flasks	11502
@NP	bisbenzimide -LRB- Hoechst 33342 ; Sigma -RRB-	11528
@NP	bisbenzimide	11528
@NP	Hoechst 33342 ; Sigma	11542
@NP	Hoechst 33342	11542
@NP	Sigma	11557
@NP	DMEM	11584
@NP	a density of 105 cells	11592
@NP	a density	11592
@NP	105 cells	11605
@NP	−	11617
@NP	1	11618
@NP	Spinal cord transection and OEG transplantation	11621
@NP	animal care and post-surgery period	11670
@NP	the experiments described in this paper	11710
@NP	the experiments	11710
@NP	this paper	11739
@NP	we	11750
@NP	SOL and EDL muscles	11758
@NP	the same rats	11781
@NP	experimental animals	11810
@NP	a previous study	11834
@NP	Ramon-Cueto et al. 2000	11852
@NP	Ramon-Cueto	11852
@NP	et al. 2000	11864
@NP	et al.	11864
@NP	2000	11871
@NP	The experimental details	11878
@NP	tissue culture	11914
@NP	surgical procedures	11930
@NP	analysis of recovery of motor and sensory functions and spinal cord histology	11951
@NP	analysis	11951
@NP	recovery of motor and sensory functions and spinal cord histology	11963
@NP	recovery of motor	11963
@NP	recovery	11963
@NP	motor	11975
@NP	sensory functions and spinal cord histology	11985
@NP	sensory functions	11985
@NP	spinal cord histology	12007
@NP	detail	12053
@NP	OEG	12078
@NP	olfactory bulbs	12101
@NP	adult Wistar rats	12120
@NP	2.5 months	12139
@NP	the animal facilities of the Centre for Molecular Biology	12160
@NP	the animal facilities	12160
@NP	the Centre for Molecular Biology	12185
@NP	the Centre	12185
@NP	Molecular Biology	12200
@NP	Madrid	12249
@NP	culture and p75-positive cells	12270
@NP	p75OEG	12302
@NP	Ramon-Cueto & Nieto-Sampedro	12343
@NP	1992	12372
@NP	1994	12378
@NP	Three weeks	12385
@NP	the primary cultures	12411
@NP	2 weeks after OEG purification	12433
@NP	2 weeks	12433
@NP	OEG purification	12447
@NP	p75OEG cells	12465
@NP	the flasks	12497
@NP	a nuclear fluorochrome	12523
@NP	culture medium	12563
@NP	transplantation	12591
@NP	Twenty-eight adult female Wistar rats -LRB- 2.5 months old , 200 -- 230 g -RRB-	12608
@NP	Twenty-eight adult female Wistar rats	12608
@NP	2.5 months old , 200 -- 230 g	12647
@NP	2.5 months old	12647
@NP	200 -- 230 g	12663
@NP	200	12663
@NP	230 g	12667
@NP	a mixture , in the same syringe ,	12699
@NP	a mixture	12699
@NP	the same syringe	12713
@NP	0.04 ml of medetomidine -LRB- Domtor , Pfizer -RRB-	12734
@NP	0.04 ml	12734
@NP	medetomidine -LRB- Domtor , Pfizer -RRB-	12745
@NP	medetomidine	12745
@NP	Domtor	12759
@NP	Pfizer	12767
@NP	0.15 ml of ketamine -LRB- from a stock of 25 mg ml − 1 -RRB-	12779
@NP	0.15 ml	12779
@NP	ketamine -LRB- from a stock of 25 mg ml − 1 -RRB-	12790
@NP	ketamine	12790
@NP	a stock of 25 mg ml − 1	12805
@NP	a stock	12805
@NP	25 mg ml − 1	12816
@NP	25 mg ml −	12816
@NP	1	12825
@NP	The need for supplemental doses of anaesthesia	12829
@NP	The need	12829
@NP	supplemental doses of anaesthesia	12842
@NP	supplemental doses	12842
@NP	anaesthesia	12864
@NP	the withdrawal reflex	12903
@NP	both the fore and hind paws	12928
@NP	the fore	12933
@NP	hind paws	12946
@NP	pin prick/dull stimulation of the wrist and ankle joints	12963
@NP	pin prick/dull stimulation	12963
@NP	the wrist and ankle joints	12993
@NP	the tail	13039
@NP	A laminectomy	13049
@NP	all animals	13080
@NP	thoracic segments 8 and 9 -LRB- T8 -- T9 -RRB-	13102
@NP	thoracic segments 8 and 9	13102
@NP	thoracic segments	13102
@NP	T8 -- T9	13129
@NP	T8	13129
@NP	T9	13132
@NP	19 rats	13140
@NP	the dura	13148
@NP	the spinal cords	13172
@NP	microscissors	13216
@NP	The stumps	13231
@NP	completeness of the lesion	13264
@NP	completeness	13264
@NP	the lesion	13280
@NP	Nine paraplegic rats -LRB- SCT+CT animals , n = 9 -RRB-	13292
@NP	Nine paraplegic rats	13292
@NP	SCT+CT animals , n = 9	13314
@NP	SCT+CT animals	13314
@NP	n = 9	13330
@NP	n	13330
@NP	9	13333
@NP	stereotaxic injections of Hoechst-labelled OEG	13345
@NP	stereotaxic injections	13345
@NP	Hoechst-labelled OEG	13371
@NP	cord stumps	13400
@NP	four sites	13418
@NP	the middle line	13433
@NP	1 mm	13457
@NP	the stump border	13466
@NP	a sterile glass needle as previously described	13490
@NP	a sterile glass needle	13490
@NP	Ramon-Cueto	13538
@NP	et al. 1998 , 2000	13550
@NP	et al.	13550
@NP	1998	13557
@NP	2000	13563
@NP	Each site	13570
@NP	0.5 μl of a suspension containing 50 000 cells -LRB- 200 000 per stump -RRB-	13589
@NP	0.5 μl	13589
@NP	a suspension containing 50 000 cells -LRB- 200 000 per stump -RRB-	13599
@NP	a suspension	13599
@NP	50 000 cells -LRB- 200 000 per stump -RRB-	13623
@NP	50 000 cells	13623
@NP	200 000 per stump	13637
@NP	200 000	13637
@NP	stump	13649
@NP	Spinal cord	13657
@NP	non-transplanted animals -LRB- SCT , n = 11 -RRB-	13681
@NP	non-transplanted animals	13681
@NP	SCT , n = 11	13707
@NP	SCT	13707
@NP	n = 11	13712
@NP	n	13712
@NP	11	13715
@NP	0.5 μl of medium devoid of cells in the same spinal cord locations	13738
@NP	0.5 μl	13738
@NP	medium devoid of cells in the same spinal cord locations	13748
@NP	cells in the same spinal cord	13765
@NP	cells	13765
@NP	the same spinal cord	13774
@NP	Eight rats	13806
@NP	sham operated -LRB- C , control un-injured group , n = 8 -RRB-	13822
@NP	sham	13822
@NP	C , control un-injured group , n = 8	13837
@NP	C	13837
@NP	control un-injured group , n = 8	13840
@NP	control un-injured group	13840
@NP	n = 8	13866
@NP	n	13866
@NP	8	13869
@NP	no spinal cord transection and no injections	13873
@NP	no spinal cord transection	13873
@NP	no injections	13904
@NP	The injury site	13934
@NP	gelfoam	13967
@NP	the muscles and skin	13976
@NP	washedwith antiseptic solution.Animals	14019
@NP	a heating pad	14071
@NP	they	14091
@NP	surgery	14131
@NP	all rats	14140
@NP	a subcutaneous injectionof 1 mlof lactateRinger solution	14158
@NP	andmagnesium metamizol -LRB- Nolotil , Boeringer Ingelheim -RRB- as analgesic	14215
@NP	andmagnesium metamizol -LRB- Nolotil , Boeringer Ingelheim -RRB-	14215
@NP	andmagnesium metamizol	14215
@NP	Nolotil	14239
@NP	Boeringer Ingelheim	14248
@NP	analgesic	14272
@NP	Augmentine	14283
@NP	amoxyciline	14295
@NP	clavulanic acid , 1 g -- 200 mg , GlaxoSmithKline	14307
@NP	clavulanic acid	14307
@NP	1 g -- 200 mg	14324
@NP	1 g	14324
@NP	200 mg	14328
@NP	GlaxoSmithKline	14336
@NP	that time and twice more every 8 h.	14374
@NP	that time	14374
@NP	every 8 h.	14399
@NP	Bladder expression	14410
@NP	twice a day	14443
@NP	establishment of reflex voidance	14461
@NP	establishment	14461
@NP	reflex voidance	14478
@NP	approximately 10 days	14495
@NP	this period	14525
@NP	residual urine	14538
@NP	everyday fromthe bladder of all paraplegic rats	14565
@NP	everyday fromthe bladder	14565
@NP	all paraplegic rats	14593
@NP	the risk of infections	14624
@NP	the risk	14624
@NP	infections	14636
@NP	Any complication	14648
@NP	the spinal cord lesion	14678
@NP	i.e.	14702
@NP	bladder infection	14707
@NP	autonomic disreflexia	14726
@NP	ulcers	14749
@NP	failure of the kidneys	14757
@NP	failure	14757
@NP	the kidneys	14768
@NP	others	14787
@NP	the post-surgery period	14816
@NP	protocols	14863
@NP	those	14886
@NP	human patients	14900
@NP	the Spinal Cord Injury Unit of the University Hospital La Fe	14918
@NP	the Spinal Cord Injury Unit	14918
@NP	the University Hospital La Fe	14949
@NP	Valencia	14980
@NP	the National Paraplegics Hospital of Toledo , Spain	14994
@NP	the National Paraplegics Hospital	14994
@NP	Toledo , Spain	15031
@NP	Santos-Benito	15050
@NP	et al. -LRB- 2006 -RRB-	15064
@NP	et al.	15064
@NP	2006	15072
@NP	a detailed description of the post-operative care of these paraplegic rats	15082
@NP	a detailed description	15082
@NP	the post-operative care of these paraplegic rats	15108
@NP	the post-operative care	15108
@NP	these paraplegic rats	15135
@NP	recovery from surgery	15165
@NP	recovery	15165
@NP	surgery	15179
@NP	all animals	15188
@NP	an open field every day	15244
@NP	an open field	15244
@NP	every day	15258
@NP	20 min	15272
@NP	inclined grids of different level of difficulty	15310
@NP	inclined grids	15310
@NP	different level of difficulty	15328
@NP	different level	15328
@NP	difficulty	15347
@NP	a function of the slope	15361
@NP	a function	15361
@NP	the slope	15375
@NP	3 to 7 months	15391
@NP	post-surgery the improvement of motor and sensory function	15404
@NP	post-surgery the improvement	15404
@NP	motor and sensory function	15436
@NP	all rats -LRB- Ramon-Cueto et al. 2000 -RRB-	15479
@NP	all rats	15479
@NP	Ramon-Cueto	15489
@NP	et al. 2000	15501
@NP	et al.	15501
@NP	2000	15508
@NP	Recovery of voluntary movement of the hind limbs	15515
@NP	Recovery	15515
@NP	voluntary movement of the hind limbs	15527
@NP	voluntary movement	15527
@NP	the hind limbs	15549
@NP	a climbing test	15583
@NP	discerning between local reflex activity and real voluntary movement	15612
@NP	discerning	15612
@NP	local reflex activity and real voluntary movement	15631
@NP	local reflex activity	15631
@NP	real voluntary movement	15657
@NP	Seven months post-surgery	15682
@NP	animals	15709
@NP	a restricted amount of standard laboratory chow	15726
@NP	a restricted amount	15726
@NP	standard laboratory chow	15749
@NP	an individual basis	15789
@NP	body weight	15822
@NP	a range of 270	15844
@NP	a range	15844
@NP	270	15855
@NP	300 g.	15859
@NP	300	15859
@NP	g.	15863
@NP	this period	15872
@NP	animals	15884
@NP	ad libitum	15912
@NP	killing	15929
@NP	All animals	15938
@NP	a second surgery	15960
@NP	tracer injection 7 months and 1 week	15981
@NP	tracer injection 7 months	15981
@NP	tracer injection	15981
@NP	7 months	15998
@NP	1 week	16011
@NP	the first surgery	16024
@NP	They	16043
@NP	an isoflurane-based gaseous anaesthesia	16072
@NP	induction : 2 l min − 1 O2	16113
@NP	induction	16113
@NP	2 l min − 1 O2	16124
@NP	2 l min −	16124
@NP	1 O2	16132
@NP	1 l min − 1 N2O	16138
@NP	1 l min −	16138
@NP	1 N2O	16146
@NP	3.5 % isoflurane	16156
@NP	2 min ; maintenance : 0.8 l min − 1 O2 , 0.4 l min − 1 N2O and 2.5 % isoflurane	16176
@NP	2 min	16176
@NP	maintenance	16183
@NP	0.8 l min − 1 O2	16196
@NP	0.8 l min −	16196
@NP	1 O2	16206
@NP	0.4 l min − 1 N2O and 2.5 % isoflurane	16212
@NP	0.4 l min − 1 N2O	16212
@NP	0.4 l min −	16212
@NP	1 N2O	16222
@NP	2.5 % isoflurane	16232
@NP	the same treatments -LRB- antibiotics and analgesics -RRB- described above	16262
@NP	the same treatments	16262
@NP	antibiotics and analgesics	16283
@NP	antibiotics	16283
@NP	analgesics	16299
@NP	Three weeks later	16328
@NP	8 months after the first surgery	16347
@NP	8 months	16347
@NP	the first surgery	16362
@NP	animals	16381
@NP	a mixture of Domtor	16420
@NP	a mixture	16420
@NP	Domtor	16433
@NP	ketamine as described above	16444
@NP	ketamine	16444
@NP	soleus -LRB- SOL -RRB-	16477
@NP	soleus	16477
@NP	SOL	16485
@NP	extensor digitorum longus	16494
@NP	EDL	16521
@NP	muscles of both hind limbs	16526
@NP	muscles	16526
@NP	both hind limbs	16537
@NP	all rats	16601
@NP	saline and fixative -LRB- 4 % paraformaldehyde -RRB-	16629
@NP	saline and fixative	16629
@NP	4 % paraformaldehyde	16650
@NP	4 %	16650
@NP	paraformaldehyde	16653
@NP	their spinal cords dissected for histological analysis , as previously reported	16675
@NP	their spinal cords	16675
@NP	histological analysis , as previously reported	16708
@NP	histological analysis	16708
@NP	Ramon-Cueto	16755
@NP	et al. 2000	16767
@NP	et al.	16767
@NP	2000	16774
@NP	All experimental procedures	16781
@NP	the guidelines	16818
@NP	the AutonomousUniversity ofMadridand theHigherCouncil	16846
@NP	Scientific Research of Spain	16903
@NP	Scientific Research	16903
@NP	Spain	16926
@NP	the normal procedures	16942
@NP	animal welfare -LRB- Real Decreto 223/88 , BOE of 18 ofMarch -RRB-	16974
@NP	animal welfare	16974
@NP	Real Decreto 223/88 , BOE of 18 ofMarch	16990
@NP	Real Decreto	16990
@NP	223/88 , BOE of 18 ofMarch	17003
@NP	223/88	17003
@NP	BOE of 18 ofMarch	17011
@NP	BOE	17011
@NP	18 ofMarch	17018
@NP	the recommendations	17045
@NP	Care	17091
@NP	Laboratory Animals	17107
@NP	US Department of Health and Human Services , NIH	17127
@NP	US Department	17127
@NP	Health and Human Services	17144
@NP	NIH	17171
@NP	laws and regulations	17187
@NP	the protection of animals	17211
@NP	the protection	17211
@NP	animals	17229
@NP	the advice of specialized personnel	17244
@NP	the advice	17244
@NP	specialized personnel	17258
@NP	Muscle dissection and preparation of tissue samples Eight months	17281
@NP	Muscle dissection and preparation	17281
@NP	tissue samples	17318
@NP	Eight months	17333
@NP	the first intervention	17352
@NP	all animals	17376
@NP	this section	17443
@NP	SOL and EDL muscles of both hind limbs	17457
@NP	SOL and EDL muscles	17457
@NP	both hind limbs	17480
@NP	Tissue blocks	17550
@NP	the muscle belly	17583
@NP	isopentane chilled with liquid nitrogen	17603
@NP	isopentane	17603
@NP	liquid nitrogen	17627
@NP	− 70 ◦ C	17657
@NP	Cryostat serial cross-sections prepared at − 20 ◦ C	17679
@NP	Cryostat serial cross-sections	17679
@NP	− 20 ◦ C	17721
@NP	either gelatin-coated or silanized slides , for immunohistochemistry ,	17742
@NP	either gelatin-coated or silanized slides	17742
@NP	immunohistochemistry	17789
@NP	qualitative and quantitative histochemistry	17831
@NP	The remainder of the muscle	17876
@NP	The remainder	17876
@NP	the muscle	17893
@NP	liquid nitrogen	17918
@NP	− 70 ◦ C	17952
@NP	electrophoresis	17973
@NP	Immunohistochemistry and histochemistry Immunohistochemical analysis	17990
@NP	myosin heavy chain -LRB- MHC -RRB-	18062
@NP	myosin heavy chain	18062
@NP	MHC	18082
@NP	isoform expression in individual fibres	18087
@NP	isoform expression	18087
@NP	individual fibres	18109
@NP	10μm thick serial cryostat cross-sections	18144
@NP	a series of monoclonal antibodies -LRB- Mabs , Table	18199
@NP	a series	18199
@NP	monoclonal antibodies -LRB- Mabs , Table	18211
@NP	monoclonal antibodies	18211
@NP	Mabs	18234
@NP	Table	18240
@NP	1 -RRB- specific for rat MHC isoforms	18246
@NP	specific	18249
@NP	rat MHC isoforms	18262
@NP	Schiaffino et al. 1989	18280
@NP	Schiaffino	18280
@NP	et al. 1989	18291
@NP	et al.	18291
@NP	1989	18298
@NP	Rivero	18320
@NP	et al. -LRB- 1999 -RRB-	18327
@NP	et al.	18327
@NP	1999	18335
@NP	Background staining	18886
@NP	additional serial sections incubated without primary antibody	18924
@NP	additional serial sections	18924
@NP	primary antibody	18969
@NP	Muscle fibres	18987
@NP	MHC content	19021
@NP	MHC	19021
@NP	their individual patterns of Mab reactivity	19046
@NP	their individual patterns	19046
@NP	Mab reactivity	19075
@NP	Table 1	19107
@NP	Seven fibre types	19116
@NP	four	19151
@NP	unique MHC isoforms	19167
@NP	I , IIA , IID/X and IIB	19199
@NP	I	19199
@NP	IIA	19202
@NP	IID/X	19207
@NP	IIB	19217
@NP	three additional mixed fibre types	19226
@NP	two MHCs isoforms I + IIA , IIA+IIX / D -LRB- IIAD/X -RRB- and IID/X	19275
@NP	two MHCs isoforms I	19275
@NP	two MHCs isoforms	19275
@NP	I	19293
@NP	IIA , IIA+IIX / D -LRB- IIAD/X -RRB-	19296
@NP	IIA	19296
@NP	IIA+IIX / D -LRB- IIAD/X -RRB-	19301
@NP	IIA+IIX / D	19301
@NP	IIA+IIX	19301
@NP	D	19309
@NP	IIAD/X	19312
@NP	IID/X	19324
@NP	IIB -LRB- IID/XB -RRB-	19330
@NP	IIB	19330
@NP	IID/XB	19335
@NP	Two additional serial cross-sections	19344
@NP	qualitative assessment of myofibrillar ATPase activity	19398
@NP	qualitative assessment	19398
@NP	myofibrillar ATPase activity	19424
@NP	alkaline -LRB- pH 10.45 -RRB- and acid -LRB- pH 4.45 -RRB- pre-incubations	19464
@NP	alkaline -LRB- pH 10.45 -RRB-	19464
@NP	alkaline	19464
@NP	pH 10.45	19474
@NP	acid -LRB- pH 4.45 -RRB- pre-incubations	19488
@NP	acid	19488
@NP	pH 4.45	19494
@NP	pre-incubations	19503
@NP	a modification -LRB- Nwoye et al. 1982 -RRB-	19526
@NP	a modification	19526
@NP	Nwoye et al. 1982	19542
@NP	Nwoye	19542
@NP	et al. 1982	19548
@NP	et al.	19548
@NP	1982	19555
@NP	the Brooke and Kaiser method -LRB- Brooke & Kaiser , 1970 -RRB-	19564
@NP	the Brooke and Kaiser method	19564
@NP	Brooke & Kaiser	19594
@NP	1970	19611
@NP	the staining intensity after alkaline pre-incubation	19631
@NP	the staining intensity	19631
@NP	alkaline pre-incubation	19660
@NP	pure muscle fibres	19685
@NP	type I -LRB- white -RRB-	19723
@NP	type I	19723
@NP	IIB -LRB- grey -RRB-	19739
@NP	IIB	19739
@NP	IIA and IID/X -LRB- black -RRB-	19754
@NP	IIA and IID/X	19754
@NP	the mATPase reaction after acid pre-incubation	19788
@NP	the mATPase reaction	19788
@NP	acid pre-incubation	19815
@NP	distinction of fibre types	19848
@NP	distinction	19848
@NP	fibre types	19863
@NP	intensity	19897
@NP	type I -LRB- black -RRB-	19908
@NP	type I	19908
@NP	IIA -LRB- white -RRB-	19924
@NP	IIA	19924
@NP	IID/X and IIB -LRB- intermediate intensity -RRB-	19940
@NP	IID/X and IIB	19940
@NP	intermediate intensity	19955
@NP	a continuum of staining intensities	19994
@NP	a continuum	19994
@NP	staining intensities	20009
@NP	observedwithin fast-twitchsubtypes -LRB- Delp & Duan ,1996 -RRB-	20034
@NP	observedwithin fast-twitchsubtypes	20034
@NP	Delp & Duan ,1996	20070
@NP	Delp	20070
@NP	Duan ,1996	20075
@NP	Five consecutive cross-sections	20087
@NP	each enzyme histochemical assay	20133
@NP	succinate	20166
@NP	dehydrogenase -LRB- SDH -RRB-	20176
@NP	dehydrogenase	20176
@NP	SDH	20191
@NP	glycerol-3-phosphate dehydrogenase -LRB- GPDH -RRB-	20200
@NP	glycerol-3-phosphate dehydrogenase	20200
@NP	GPDH	20236
@NP	Three of them	20244
@NP	Three	20244
@NP	them	20253
@NP	medium	20276
@NP	substrate -LRB- either succinic acid or glycerol-3-phosphate -RRB-	20294
@NP	substrate	20294
@NP	succinic acid or glycerol-3-phosphate	20312
@NP	the other two , incubated in the absence of substrate ,	20352
@NP	the other two	20352
@NP	the absence of substrate	20380
@NP	the absence	20380
@NP	substrate	20395
@NP	non-specific staining	20431
@NP	Mean muscle	20454
@NP	oxidative capacity	20466
@NP	means	20501
@NP	quantitative SDH histochemistry	20510
@NP	10 μm thick sections following the procedure	20555
@NP	10 μm thick sections	20555
@NP	the procedure	20586
@NP	Blanco	20624
@NP	et al. -LRB- 1988 -RRB-	20631
@NP	et al.	20631
@NP	1988	20639
@NP	The activity of GPDH , an indirect marker of glycolytic capacity ,	20646
@NP	The activity of GPDH	20646
@NP	The activity	20646
@NP	GPDH	20662
@NP	an indirect marker of glycolytic capacity	20668
@NP	an indirect marker	20668
@NP	glycolytic capacity	20690
@NP	14 μm thick sections	20729
@NP	Martin et al. -LRB- 1985 -RRB-	20763
@NP	Martin et al.	20763
@NP	Martin	20763
@NP	et al.	20770
@NP	1985	20778
@NP	staining	20791
@NP	sections	20801
@NP	2	20832
@NP	3 h with a computerized image-processing system -LRB- see below -RRB-	20834
@NP	3 h	20834
@NP	a computerized image-processing system -LRB- see below -RRB-	20843
@NP	a computerized image-processing system	20843
@NP	SDH and GPDH activities	20901
@NP	at least 15 or 30 min	20940
@NP	at least 15	20940
@NP	30 min	20955
@NP	termination of the reaction within this time	20977
@NP	termination	20977
@NP	the reaction within this time	20992
@NP	the reaction	20992
@NP	this time	21012
@NP	enzymatic activities	21030
@NP	steady-state rates	21070
@NP	These activities	21090
@NP	optical density per time unit -LRB- OD min − 1 -RRB-	21125
@NP	optical density	21125
@NP	time unit -LRB- OD min − 1 -RRB-	21145
@NP	time unit	21145
@NP	OD min − 1	21156
@NP	OD min −	21156
@NP	1	21163
@NP	Quantitative tissue analysis	21167
@NP	appropriate staining	21202
@NP	a region -LRB- 750 000 μm2 -RRB-	21224
@NP	a region	21224
@NP	750 000 μm2	21234
@NP	750 000	21234
@NP	μm2	21242
@NP	the cross-sections containing between 125 and 175 fibres per muscle sample	21250
@NP	the cross-sections	21250
@NP	between 125 and 175 fibres per muscle sample	21280
@NP	between 125 and 175 fibres	21280
@NP	muscle sample	21311
@NP	further analysis	21342
@NP	Serial sections	21360
@NP	regions free of artefacts	21398
@NP	regions	21398
@NP	artefacts	21414
@NP	They	21425
@NP	a Leica DMLS microscope	21465
@NP	Leica Microsistemas	21490
@NP	Barcelona	21511
@NP	Spain	21522
@NP	a high-resolution colour	21530
@NP	charge-coupled device Leica ICCA camera	21555
@NP	Leica Microsistemas	21596
@NP	Barcelona	21617
@NP	Spain	21628
@NP	an eight-bit Matrox Meteor II frame-grabber	21640
@NP	Matrox Electronic Systems Ltd , Barcelona , Spain	21685
@NP	Matrox Electronic Systems Ltd	21685
@NP	Barcelona , Spain	21716
@NP	an image-analysing software	21749
@NP	Visiolog 5	21778
@NP	Noemi , Microptic	21790
@NP	Barcelona , Spain	21808
@NP	Serial sections	21827
@NP	the fibres	21877
@NP	their immunohistochemical stains	21927
@NP	The fibre type distribution of each muscle sample	21961
@NP	The fibre type distribution	21961
@NP	each muscle sample	21992
@NP	immunohistochemistry	22037
@NP	the relative frequency of the various fibre types	22070
@NP	the relative frequency	22070
@NP	the various fibre types	22096
@NP	The same region of the serial sections stained for quantitative SDH and GPDH	22121
@NP	The same region	22121
@NP	the serial sections stained for quantitative SDH and GPDH	22140
@NP	the serial sections	22140
@NP	quantitative SDH and GPDH	22172
@NP	a grey level -LRB- range of grey level 0 -- 255 -RRB- image	22215
@NP	range of grey level 0 -- 255	22229
@NP	range of grey level	22229
@NP	range	22229
@NP	grey level	22238
@NP	0 -- 255	22249
@NP	each sample analysed	22267
@NP	each sample	22267
@NP	a mean optical density -LRB- OD -RRB-	22289
@NP	a mean optical density	22289
@NP	OD	22313
@NP	each quantitative histochemical assay	22336
@NP	values	22378
@NP	OD min − 1	22397
@NP	OD min −	22397
@NP	1	22404
@NP	each enzyme assay	22411
@NP	the mean value	22430
@NP	the three sections	22448
@NP	substrate minus the mean of the two tissue blank sections	22481
@NP	substrate	22481
@NP	the mean of the two tissue blank sections	22497
@NP	the mean	22497
@NP	the two tissue blank sections	22509
@NP	the enzyme activity of a single muscle sample	22561
@NP	the enzyme activity	22561
@NP	a single muscle sample	22584
@NP	a number of factors	22614
@NP	a number	22614
@NP	factors	22626
@NP	the reliability of histochemical enzymeactivity determination	22648
@NP	the reliability	22648
@NP	histochemical enzymeactivity determination	22667
@NP	we	22711
@NP	the measurement precision	22723
@NP	several sources of variability	22765
@NP	several sources	22765
@NP	variability	22784
@NP	thickness of the tissue , image analysis system , etc.	22797
@NP	thickness of the tissue	22797
@NP	thickness	22797
@NP	the tissue	22810
@NP	image analysis system	22822
@NP	repeated measurements	22854
@NP	the same single fields	22879
@NP	three consecutive sections	22905
@NP	The coefficient	22933
@NP	variation for triplicate measurement of OD in each histochemical assay	22952
@NP	variation	22952
@NP	triplicate measurement of OD in each histochemical assay	22966
@NP	triplicate measurement	22966
@NP	OD in each histochemical assay	22992
@NP	OD	22992
@NP	each histochemical assay	22998
@NP	5 %	23040
@NP	The cross-sectional areas of 125 individual muscle fibres per sample	23044
@NP	The cross-sectional areas	23044
@NP	125 individual muscle fibres per sample	23073
@NP	125 individual muscle fibres	23073
@NP	sample	23106
@NP	the same computerized video display image-analysis system previously described	23147
@NP	the same computerized video display image-analysis system	23147
@NP	values	23230
@NP	each muscle biopsy specimen	23266
@NP	Fibre size	23295
@NP	the histochemical preparations of SDH	23324
@NP	the histochemical preparations	23324
@NP	SDH	23358
@NP	this procedure	23368
@NP	no negative impact onmuscle fibre size -LRB- Snow & Guy , 1980 -RRB-	23387
@NP	no negative impact onmuscle fibre size	23387
@NP	Snow & Guy	23427
@NP	1980	23439
@NP	Two-dimensional electrophoresis and evaluation	23446
@NP	the relative proportions	23496
@NP	myosin light chain -LRB- MLC -RRB- isoforms and variants thereof	23524
@NP	myosin light chain -LRB- MLC -RRB-	23524
@NP	myosin light chain	23524
@NP	MLC	23544
@NP	isoforms and variants thereof	23549
@NP	isoforms and variants	23549
@NP	homogenization	23586
@NP	sample preparation	23602
@NP	twodimensional	23625
@NP	2D	23641
@NP	electrophoresis of proteins	23645
@NP	electrophoresis	23645
@NP	proteins	23664
@NP	Hernando & Manso , 1997 ; Gonzalez et al. 2002	23725
@NP	Hernando & Manso , 1997 ; Gonzalez et al.	23725
@NP	Hernando & Manso , 1997	23725
@NP	Hernando & Manso	23725
@NP	1997	23743
@NP	Gonzalez et al.	23749
@NP	Gonzalez	23749
@NP	et al.	23758
@NP	2002	23765
@NP	a pH range	23778
@NP	4	23792
@NP	6.5 in the first , isoelectric focusing dimension and 9	23794
@NP	6.5	23794
@NP	the first , isoelectric focusing dimension and 9	23801
@NP	the first , isoelectric focusing dimension	23801
@NP	9	23847
@NP	20 % acrylamide slab gel gradients	23849
@NP	the second dimension	23887
@NP	The resulting 2D electrophoretograms of whole muscle proteins	23909
@NP	The resulting 2D electrophoretograms	23909
@NP	whole muscle proteins	23949
@NP	0.5 % Coomassie	23987
@NP	brilliant blue R to determine the relative proportions of MLC isoforms	24002
@NP	the relative proportions of MLC isoforms	24032
@NP	the relative proportions	24032
@NP	MLC isoforms	24060
@NP	Three variants	24074
@NP	each	24092
@NP	the slow -LRB- s -RRB-	24098
@NP	fast	24115
@NP	regulatory -LRB- r -RRB-	24124
@NP	MLCs -LRB- designated 2s , 2s1 , 2s2 and 2f , 2f1 and 2f2 , respectively ,	24139
@NP	MLCs -LRB- designated 2s , 2s1 , 2s2	24139
@NP	MLCs -LRB- designated 2s , 2s1 ,	24139
@NP	MLCs	24139
@NP	designated 2s , 2s1	24145
@NP	designated 2s	24145
@NP	2s1	24160
@NP	2s2	24165
@NP	2f , 2f1 and 2f2 , respectively ,	24173
@NP	2f , 2f1 and 2f2	24173
@NP	less	24209
@NP	more acidic	24217
@NP	more	24217
@NP	as previously reported -LRB- Gonzalez et al. 2002 -RRB-	24244
@NP	as previously	24244
@NP	Gonzalez et al. 2002	24268
@NP	Gonzalez	24268
@NP	et al. 2002	24277
@NP	et al.	24277
@NP	2002	24284
@NP	Quantification of proteins in stained gels	24291
@NP	Quantification	24291
@NP	proteins in stained gels	24309
@NP	proteins	24309
@NP	gels	24329
@NP	densitometry -LRB- Bio-Rad , GS-710 , with Quantity One software v. 4.2.1 -RRB-	24354
@NP	densitometry	24354
@NP	Bio-Rad , GS-710 , with Quantity One software v. 4.2.1	24368
@NP	Bio-Rad , GS-710 ,	24368
@NP	Bio-Rad	24368
@NP	GS-710	24377
@NP	Quantity One software v. 4.2.1	24390
@NP	Quantity One software	24390
@NP	4.2.1	24414
@NP	Optical density measurements	24422
@NP	the linear absorption range	24469
@NP	Statistical and discriminant analysis of the data Data	24498
@NP	Statistical and discriminant analysis	24498
@NP	the data Data	24539
@NP	means	24571
@NP	Differences among groups	24582
@NP	Differences	24582
@NP	groups	24600
@NP	one-way analysis	24624
@NP	variance -LRB- ANOVA -RRB- using the statistical program SPSS 8.0	24644
@NP	ANOVA	24654
@NP	the statistical program SPSS	24667
@NP	8.0	24696
@NP	significance	24706
@NP	pair-wise comparisons	24736
@NP	a Bonferroni post hoc test	24779
@NP	the homogeneity of variance	24812
@NP	the homogeneity	24812
@NP	variance	24831
@NP	Levene statistics	24854
@NP	a Dunnett 's T3 test when the homogeneity of variance was discarded	24878
@NP	a Dunnett 's T3 test	24878
@NP	a Dunnett 's	24878
@NP	the homogeneity of variance	24903
@NP	the homogeneity	24903
@NP	variance	24922
@NP	Differences	24946
@NP	statistically significant at P <	24974
@NP	P	25003
@NP	Correlations between variables	25012
@NP	Correlations	25012
@NP	variables	25033
@NP	Pearson 's or Spearman 's tests	25063
@NP	Pearson 's or Spearman 's	25063
@NP	Pearson 's	25063
@NP	Spearman 's	25076
@NP	tests	25087
@NP	homogeneous or non-homogeneous variances , respectively	25098
@NP	homogeneous or non-homogeneous variances	25098
@NP	All the data fromthe individualmuscles of all three groups	25155
@NP	All the data fromthe individualmuscles	25155
@NP	All the data	25155
@NP	all three groups	25197
@NP	amultivariate , discriminant analysis using the package Statistica for Windows	25231
@NP	amultivariate	25231
@NP	discriminant analysis using the package Statistica for Windows	25246
@NP	discriminant analysis	25246
@NP	the package Statistica for Windows	25274
@NP	the package Statistica	25274
@NP	Windows	25301
@NP	This analysis	25310
@NP	skeletalmuscles of experimental animals	25341
@NP	skeletalmuscles	25341
@NP	experimental animals	25360
@NP	phenotype	25394
@NP	the overall characteristics of group pairs	25416
@NP	the overall characteristics	25416
@NP	group pairs	25447
@NP	their homology	25472
@NP	individual muscles	25503
@NP	one group or the other	25527
@NP	one group	25527
@NP	the other	25540
@NP	muscles of OEG-transplanted animals	25557
@NP	muscles	25557
@NP	OEG-transplanted animals	25568
@NP	those of non-transplanted and control	25612
@NP	those	25612
@NP	non-transplanted and control	25621
@NP	non-transplanted	25621
@NP	control	25642
@NP	information	25657
@NP	the impact of OEG transplants	25672
@NP	the impact	25672
@NP	OEG transplants	25686
@NP	the relative maintenance of normal skeletal muscle characteristics	25705
@NP	the relative maintenance	25705
@NP	normal skeletal muscle characteristics	25733
@NP	Statistically significant differences	25773
@NP	pair of groups -LRB- P < 0.05 -RRB-	25819
@NP	pair	25819
@NP	groups -LRB- P < 0.05 -RRB-	25827
@NP	groups	25827
@NP	P < 0.05	25835
@NP	P	25835
@NP	< 0.05	25837
@NP	<	25837
@NP	0.05	25838
@NP	the degree	25848
@NP	homology	25862
@NP	muscles from OEG-transplanted rats with those of control or non-transplanted	25874
@NP	muscles	25874
@NP	OEG-transplanted rats with those of control or non-transplanted	25887
@NP	OEG-transplanted rats	25887
@NP	those of control or non-transplanted	25914
@NP	those	25914
@NP	control or non-transplanted	25923
@NP	Mahalanobis distances	25952
@NP	Fig. 5	25992
@NP	each group pair	26003
@NP	Results Table 1 .	26021
@NP	Results	26021
@NP	Table 1	26029
@NP	Characteristics	26038
@NP	anti-myosin heavy chain -LRB- MHC -RRB-	26057
@NP	anti-myosin heavy chain	26057
@NP	MHC	26082
@NP	monoclonal antibodies -LRB- MAb -RRB-	26087
@NP	monoclonal antibodies	26087
@NP	MAb	26110
@NP	clues for the immunohistochemical identification	26119
@NP	clues	26119
@NP	the immunohistochemical identification	26129
@NP	the MHC isoforms	26171
@NP	skeletal muscle fibres Figure 1	26201
@NP	skeletal muscle fibres	26201
@NP	Figure 1	26225
@NP	Morphological characteristics	26235
@NP	fast - and slow-twitch skeletal muscles of the rat hind	26268
@NP	fast - and slow-twitch skeletal muscles	26268
@NP	the rat hind	26310
@NP	limb	26323
@NP	long-term paralysis	26338
@NP	a complete transversal section of the spinal cord	26369
@NP	a complete transversal section	26369
@NP	the spinal cord	26403
@NP	effect	26420
@NP	OEG transplantation	26430
@NP	The figure	26450
@NP	the absolute	26472
@NP	relative -LRB- body weight and muscle-somatic index -RRB- wet weights	26489
@NP	body weight and muscle-somatic index	26499
@NP	body weight	26499
@NP	muscle-somatic index	26515
@NP	fibre cross-sectional area -LRB- CSA -RRB-	26558
@NP	fibre cross-sectional area	26558
@NP	CSA	26586
@NP	the slow-twitch SOL and fast-twitch EDL muscles	26594
@NP	sham-operated controls -LRB- C , n = 8 -RRB-	26645
@NP	sham-operated controls	26645
@NP	C , n = 8	26669
@NP	C	26669
@NP	n = 8	26672
@NP	n	26672
@NP	8	26676
@NP	spinal cord-transected -LRB- SCT , n = 11 -RRB-	26680
@NP	spinal cord-transected	26680
@NP	SCT , n = 11	26704
@NP	SCT	26704
@NP	n = 11	26709
@NP	n	26709
@NP	11	26713
@NP	SCT	26721
@NP	OEG-transplanted -LRB- SCT + CT , n = 9 -RRB- rats	26726
@NP	SCT + CT	26744
@NP	SCT	26744
@NP	CT	26750
@NP	n = 9	26754
@NP	n	26754
@NP	= 9	26756
@NP	Data are	26767
@NP	Data	26767
@NP	± S.D. of the number of animals per group	26782
@NP	± S.D.	26782
@NP	the number of animals per group	26792
@NP	the number	26792
@NP	animals per group	26806
@NP	animals	26806
@NP	group	26818
@NP	both hind limbs	26847
@NP	the number of samples	26894
@NP	the number	26894
@NP	samples	26908
@NP	the number of animals per group	26926
@NP	the number	26926
@NP	animals per group	26940
@NP	animals	26940
@NP	group	26952
@NP	∗ P < 0.05 , SCT or SCT + CT versus sham-operated controls .	26959
@NP	∗ P <	26959
@NP	∗ P	26959
@NP	0.05 , SCT or SCT + CT versus sham-operated controls	26964
@NP	0.05 , SCT or SCT	26964
@NP	0.05	26964
@NP	SCT	26970
@NP	SCT	26977
@NP	CT versus sham-operated controls	26983
@NP	CT	26983
@NP	sham-operated controls	26993
@NP	Figure 2 .	27018
@NP	Figure	27018
@NP	2	27025
@NP	Histochemical changes	27028
@NP	markers	27053
@NP	energy metabolism	27064
@NP	SOL and EDL muscles	27085
@NP	the rat	27108
@NP	a complete spinal cord transection	27128
@NP	effect of OEG transplantation Cross-sections of soleus and EDL muscles	27164
@NP	effect	27164
@NP	OEG transplantation Cross-sections of soleus and EDL muscles	27174
@NP	OEG transplantation Cross-sections	27174
@NP	soleus and EDL muscles	27212
@NP	quantitative glycerol-3-phosphate dehydrogenase	27253
@NP	GPDH	27302
@NP	succinate dehydrogenase	27311
@NP	SDH	27336
@NP	histochemistry , as indicated in the Methods section	27341
@NP	histochemistry	27341
@NP	the Methods section	27373
@NP	representative sections	27397
@NP	sham-operated controls -LRB- C , n = 8 -RRB-	27424
@NP	sham-operated controls	27424
@NP	C , n = 8	27448
@NP	C	27448
@NP	n = 8	27451
@NP	n	27451
@NP	8	27455
@NP	spinal cord-transected -LRB- SCT , n = 11 -RRB- rats	27462
@NP	SCT , n = 11	27486
@NP	SCT	27486
@NP	n = 11	27491
@NP	n	27491
@NP	11	27495
@NP	two examples of SCT	27519
@NP	two examples	27519
@NP	SCT	27535
@NP	OEGs -LRB- SCT + CT , n = 9 -RRB-	27562
@NP	OEGs	27562
@NP	SCT + CT	27568
@NP	SCT	27568
@NP	CT	27574
@NP	n = 9	27578
@NP	n	27578
@NP	= 9	27580
@NP	a different degree	27593
@NP	functional recovery	27615
@NP	3 and 7	27636
@NP	good	27645
@NP	bad recovery , respectively -LRB- Ramon-Cueto et al. 2000 -RRB-	27654
@NP	bad recovery , respectively	27654
@NP	bad recovery	27654
@NP	Ramon-Cueto	27682
@NP	et al. 2000	27694
@NP	et al.	27694
@NP	2000	27701
@NP	GPDH -LRB- soleus -RRB- or SDH -LRB- EDL -RRB-	27721
@NP	GPDH	27721
@NP	soleus	27727
@NP	SDH	27738
@NP	EDL	27743
@NP	B	27749
@NP	graphic representation	27752
@NP	the quantitative histochemistry data for GPDH and SDH in both muscle types	27778
@NP	the quantitative histochemistry data	27778
@NP	GPDH and SDH	27819
@NP	muscle types	27840
@NP	Data are	27854
@NP	Data	27854
@NP	± S.D. of the number of animals per group	27869
@NP	± S.D.	27869
@NP	the number of animals per group	27879
@NP	the number	27879
@NP	animals per group	27893
@NP	animals	27893
@NP	group	27905
@NP	2-fold number of samples -LRB- both hind limbs -RRB- per group	27945
@NP	2-fold number	27945
@NP	samples -LRB- both hind limbs -RRB- per group	27962
@NP	samples -LRB- both hind limbs -RRB-	27962
@NP	samples	27962
@NP	hind limbs	27976
@NP	group	27992
@NP	∗ P < 0.05 , SCT or SCT + CT versus sham-operated controls .	27999
@NP	∗ P <	27999
@NP	∗ P	27999
@NP	0.05 , SCT or SCT + CT versus sham-operated controls	28004
@NP	0.05 , SCT or SCT	28004
@NP	0.05	28004
@NP	SCT	28010
@NP	SCT	28017
@NP	CT versus sham-operated controls	28023
@NP	CT	28023
@NP	sham-operated controls	28033
@NP	# P	28057
@NP	< 0.05 , OEG-transpanted -LRB- SCT + CT -RRB- versus non-transplanted SCT-rats	28060
@NP	< 0.05 , OEG-transpanted -LRB- SCT + CT -RRB-	28060
@NP	< 0.05 , OEG-transpanted	28060
@NP	<	28060
@NP	0.05	28062
@NP	SCT + CT	28085
@NP	SCT	28085
@NP	CT	28091
@NP	non-transplanted SCT-rats	28102
@NP	Bar -LRB- situated in the control EDL muscle for SDH histochemistry -RRB-	28129
@NP	Bar	28129
@NP	the control EDL muscle for SDH histochemistry	28146
@NP	the control EDL muscle	28146
@NP	SDH histochemistry	28173
@NP	1 μm	28203
@NP	Figure 3 .	28210
@NP	Figure	28210
@NP	3	28217
@NP	Fibre type transitions in soleus and EDL muscles of the rat	28220
@NP	Fibre type transitions	28220
@NP	soleus and EDL muscles of the rat	28246
@NP	soleus and EDL muscles	28246
@NP	the rat	28272
@NP	a complete transversal section of the spinal cord	28291
@NP	a complete transversal section	28291
@NP	the spinal cord	28325
@NP	effect of OEG transplantation Fibre typing of soleus and EDL muscles	28342
@NP	effect	28342
@NP	OEG transplantation Fibre typing of soleus and EDL muscles	28352
@NP	OEG transplantation Fibre typing	28352
@NP	soleus and EDL muscles	28388
@NP	serial cross-sections	28428
@NP	those shown in Fig.	28464
@NP	those	28464
@NP	Fig.	28479
@NP	2	28484
@NP	monoclonal antibodies	28509
@NP	different myosin heavy chain -LRB- MHC -RRB- isoforms	28548
@NP	myofibrillar ATPase	28607
@NP	pre-incubations at pH 4.45 or 10.45	28632
@NP	pre-incubations	28632
@NP	pH 4.45 or 10.45	28651
@NP	the Methods section	28685
@NP	The antibody BF-F8	28706
@NP	MHC-I	28748
@NP	BF-35	28759
@NP	all MHCs except IIX/D	28765
@NP	all MHCs	28765
@NP	IIX/D	28781
@NP	Myofibrillar ATPase	28788
@NP	acid pre-incubation at pH 4.45	28814
@NP	acid pre-incubation	28814
@NP	pH 4.45	28837
@NP	three staining intensities	28853
@NP	dark -LRB- type I -RRB-	28881
@NP	dark	28881
@NP	type I	28887
@NP	intermediate -LRB- IID/X and IIB -RRB-	28896
@NP	intermediate	28896
@NP	IID/X and IIB	28910
@NP	IID/X	28910
@NP	IIB	28920
@NP	light -LRB- IIA -RRB-	28929
@NP	light	28929
@NP	IIA	28936
@NP	Myofibrillar ATPase after alkaline pre-incubation at pH 10.45	28942
@NP	Myofibrillar ATPase	28942
@NP	alkaline pre-incubation at pH 10.45	28968
@NP	alkaline pre-incubation	28968
@NP	pH 10.45	28995
@NP	three staining intensities	29015
@NP	type I -LRB- light -RRB-	29059
@NP	type I	29059
@NP	light	29067
@NP	IIA and IID/X -LRB- dark -RRB-	29075
@NP	IIA and IID/X	29075
@NP	dark	29090
@NP	IIB -LRB- intermediate -RRB- fibres	29100
@NP	IIB	29100
@NP	intermediate	29105
@NP	fibres	29119
@NP	representative samples of soleus and EDL muscles	29130
@NP	representative samples	29130
@NP	soleus and EDL muscles	29156
@NP	sham-operated -LRB- C , n = 8 -RRB- and SCT -LRB- n = 11 -RRB-	29182
@NP	sham-operated	29182
@NP	C , n = 8	29197
@NP	C	29197
@NP	n = 8	29200
@NP	n	29200
@NP	8	29204
@NP	SCT	29211
@NP	n	29216
@NP	11	29220
@NP	two examples of SCT	29238
@NP	two examples	29238
@NP	SCT	29254
@NP	OEGs -LRB- SCT + CT , n = 9 -RRB-	29281
@NP	OEGs	29281
@NP	SCT + CT	29287
@NP	SCT	29287
@NP	CT	29293
@NP	n = 9	29297
@NP	n	29297
@NP	= 9	29299
@NP	different level	29309
@NP	functional recovery	29328
@NP	3 and 7 ,	29349
@NP	3	29349
@NP	7	29355
@NP	good and bad recovery	29368
@NP	B	29406
@NP	graphic representation	29409
@NP	the proportions of pure	29435
@NP	the proportions	29435
@NP	pure	29454
@NP	only one MHC isoform	29471
@NP	hybrid -LRB- expressing two MHC isoforms -RRB- fibres in both muscle types	29497
@NP	hybrid -LRB- expressing two MHC isoforms -RRB- fibres	29497
@NP	two MHC isoforms	29516
@NP	both muscle types	29544
@NP	Data are	29563
@NP	Data	29563
@NP	± S.D. of the number of animals per group	29578
@NP	± S.D.	29578
@NP	the number of animals per group	29588
@NP	the number	29588
@NP	animals per group	29602
@NP	animals	29602
@NP	group	29614
@NP	twice the number	29653
@NP	samples -LRB- both hind limbs were considered independently -RRB-	29673
@NP	samples	29673
@NP	hind limbs	29687
@NP	∗ P	29730
@NP	<	29733
@NP	0.05 , SCT or SCT + CT versus sham-operated ; # P < 0.05 , SCT + CT	29735
@NP	0.05 , SCT or SCT	29735
@NP	0.05	29735
@NP	SCT	29741
@NP	SCT	29748
@NP	CT versus sham-operated	29754
@NP	CT	29754
@NP	sham-operated	29764
@NP	# P < 0.05	29779
@NP	# P <	29779
@NP	0.05	29784
@NP	SCT + CT	29790
@NP	SCT	29790
@NP	CT	29796
@NP	non-transplanted SCT rats	29806
@NP	Bars in the SCT panels	29833
@NP	Bars	29833
@NP	the SCT panels	29841
@NP	mATPase histochemistry for SOL	29873
@NP	mATPase histochemistry	29873
@NP	SOL	29900
@NP	pH 4.45	29905
@NP	EDL -LRB- pH 10.45 -RRB- muscles	29918
@NP	EDL	29918
@NP	pH 10.45	29923
@NP	1 μm	29950
@NP	Figure 4 .	29957
@NP	Figure	29957
@NP	4	29964
@NP	Transitions of essential	29967
@NP	Transitions	29967
@NP	regulatory -LRB- r -RRB- myosin light chain -LRB- MLC -RRB-	30000
@NP	regulatory -LRB- r -RRB-	30000
@NP	myosin light chain -LRB- MLC -RRB-	30015
@NP	myosin	30015
@NP	light chain -LRB- MLC -RRB-	30022
@NP	light chain	30022
@NP	MLC	30035
@NP	isoforms and variants	30040
@NP	thereof , in soleus and EDL muscles	30062
@NP	soleus and EDL	30074
@NP	the rat	30100
@NP	a complete transversal section of the spinal cord	30118
@NP	a complete transversal section	30118
@NP	the spinal cord	30152
@NP	effect of OEG transplantation The proportions of e	30169
@NP	effect of OEG transplantation	30169
@NP	effect	30169
@NP	OEG transplantation	30179
@NP	The proportions of e	30199
@NP	The proportions	30199
@NP	rMLC isoforms	30225
@NP	their variants	30246
@NP	soleus or EDL muscles	30265
@NP	Coomassie	30306
@NP	blue-stained two-dimensional -LRB- 2D -RRB- electrophoretograms	30316
@NP	2D	30346
@NP	whole muscle protein homogenates	30373
@NP	indicated	30410
@NP	the Methods section	30423
@NP	Different variants	30444
@NP	the slow -LRB- s -RRB- and fast -LRB- f -RRB- rMLC	30466
@NP	s	30476
@NP	f	30489
@NP	2s , 2s1 and 2s2 and 2f , 2f1 and 2f2 ,	30506
@NP	2s	30506
@NP	2s1 and 2s2 and 2f , 2f1 and 2f2	30510
@NP	2s1 and 2s2	30510
@NP	2f , 2f1 and 2f2	30526
@NP	less to more acidic , respectively	30548
@NP	less	30548
@NP	more acidic , respectively	30556
@NP	more acidic	30556
@NP	Gonzalez et al. 2002	30623
@NP	Gonzalez	30623
@NP	et al. 2002	30632
@NP	et al.	30632
@NP	2002	30639
@NP	The figure	30646
@NP	representative 2D patterns	30668
@NP	the graphic representation	30709
@NP	the percentage distributions of r - and eMLC isoforms -LRB- panels a and b -RRB-	30739
@NP	the percentage distributions	30739
@NP	r - and eMLC isoforms	30771
@NP	panels a and b	30793
@NP	panels	30793
@NP	a and b	30800
@NP	rMLC variants -LRB- panels c and d -RRB-	30813
@NP	rMLC variants	30813
@NP	panels c and d	30828
@NP	SOL -LRB- upper panel -RRB- and EDL -LRB- bottom panel -RRB-	30847
@NP	SOL	30847
@NP	upper panel	30852
@NP	EDL	30869
@NP	bottom panel	30874
@NP	muscles	30888
@NP	C , sham-operated controls -LRB- n = 8 -RRB-	30897
@NP	C	30897
@NP	sham-operated controls -LRB- n = 8 -RRB-	30900
@NP	sham-operated controls	30900
@NP	n	30924
@NP	8	30928
@NP	SCT , spinal cord-transected -LRB- n = 11 -RRB- , SCT	30932
@NP	SCT	30932
@NP	spinal cord-transected -LRB- n = 11 -RRB- , SCT	30937
@NP	spinal cord-transected	30937
@NP	n	30961
@NP	11	30965
@NP	SCT	30970
@NP	CT , SCT rats transplanted with OEGs -LRB- n = 9 -RRB-	30976
@NP	CT	30976
@NP	SCT rats transplanted with OEGs -LRB- n = 9 -RRB-	30980
@NP	SCT rats	30980
@NP	OEGs -LRB- n = 9 -RRB-	31007
@NP	OEGs	31007
@NP	n	31013
@NP	9	31017
@NP	Data are	31566
@NP	Data	31566
@NP	± S.D. of the number of animals per group	31581
@NP	± S.D.	31581
@NP	the number of animals per group	31591
@NP	the number	31591
@NP	animals per group	31605
@NP	animals	31605
@NP	group	31617
@NP	twice the number of muscles	31657
@NP	twice the number	31657
@NP	muscles	31677
@NP	∗ P < 0.05 , SCT or SCT + CT versus sham-operated controls .	31686
@NP	∗ P <	31686
@NP	∗ P	31686
@NP	0.05 , SCT or SCT + CT versus sham-operated controls	31691
@NP	0.05 , SCT or SCT	31691
@NP	0.05	31691
@NP	SCT	31697
@NP	SCT	31704
@NP	CT versus sham-operated controls	31710
@NP	CT	31710
@NP	sham-operated controls	31720
@NP	Figure 5 .	31745
@NP	Figure	31745
@NP	5	31752
@NP	Phenotypic classification	31755
@NP	individual hind limb muscles	31784
@NP	OEG-transplanted rats	31816
@NP	relation	31841
@NP	non-transplanted and sham-operated controls	31853
@NP	means	31900
@NP	multivariate discriminant analysis Individual SOL and EDL muscles	31909
@NP	left and right hind limbs of all experimental rats	31978
@NP	left and right hind limbs	31978
@NP	all experimental rats	32007
@NP	different groups	32050
@NP	a function of a cohort of phenotypic characteristics	32070
@NP	a function	32070
@NP	a cohort of phenotypic characteristics	32084
@NP	a cohort	32084
@NP	phenotypic characteristics	32096
@NP	means of discriminant analysis	32126
@NP	means	32126
@NP	discriminant analysis	32135
@NP	The discriminant model for the SOL	32158
@NP	The discriminant model	32158
@NP	the SOL	32185
@NP	the following variables : wet weight , muscle-somatic index	32202
@NP	the following variables	32202
@NP	wet weight , muscle-somatic index	32227
@NP	wet weight	32227
@NP	muscle-somatic index	32239
@NP	percentage of fibre types	32261
@NP	percentage	32261
@NP	fibre types	32275
@NP	I	32287
@NP	I	32290
@NP	IIA , IIA , IIAD/X and IIX/D	32294
@NP	SDH	32322
@NP	GPDH	32327
@NP	CSA	32333
@NP	fraction	32338
@NP	slow rMLC isoform	32350
@NP	total rMLC	32373
@NP	rMLCs/rMLCt	32385
@NP	fraction of slow eMLC isoform from total eMLC -LRB- eMLCs/eMLCt -RRB-	32399
@NP	fraction	32399
@NP	slow eMLC isoform from total eMLC -LRB- eMLCs/eMLCt -RRB-	32411
@NP	slow eMLC isoform	32411
@NP	total eMLC -LRB- eMLCs/eMLCt -RRB-	32434
@NP	total eMLC	32434
@NP	eMLCs/eMLCt	32446
@NP	variant 2s/rMLCt	32460
@NP	variant 2s/rMLCs	32478
@NP	variant 2f/rMLCt	32496
@NP	variant 2f/rMLCf	32517
@NP	The same parameters	32535
@NP	the EDL muscle	32580
@NP	the percentage of fibre types IIX/DB and IIB	32608
@NP	the percentage	32608
@NP	fibre types IIX/DB and IIB	32626
@NP	fibre types IIX/DB	32626
@NP	IIB	32649
@NP	types I and IIA	32674
@NP	types I	32674
@NP	IIA	32686
@NP	Circles	32691
@NP	the relative distribution of sham-operated rat control muscles	32709
@NP	the relative distribution	32709
@NP	sham-operated rat control muscles	32738
@NP	all the phenotypic markers mentioned above	32777
@NP	all the phenotypic markers	32777
@NP	squares	32845
@NP	SCT rats	32863
@NP	1 -- 9	32873
@NP	individual SCT	32886
@NP	+ CT animals , numbered from best -LRB- 1 -RRB- to worst -LRB- 9 -RRB-	32901
@NP	CT animals	32903
@NP	best -LRB- 1 -RRB-	32929
@NP	best	32929
@NP	1	32935
@NP	worst -LRB- 9 -RRB-	32941
@NP	worst	32941
@NP	9	32948
@NP	the scores of behavioural tests -LRB- Ramon-Cueto et al. 2000 -RRB-	32974
@NP	the scores	32974
@NP	behavioural tests -LRB- Ramon-Cueto et al. 2000 -RRB-	32988
@NP	behavioural tests	32988
@NP	Ramon-Cueto	33007
@NP	et al. 2000	33019
@NP	et al.	33019
@NP	2000	33026
@NP	symbols	33049
@NP	left and right hind limb muscles , respectively	33067
@NP	left and right hind limb muscles	33067
@NP	both muscle types	33119
@NP	OEG-transplanted animals	33138
@NP	an independent phenotypic group , different from both control and SCT animals	33173
@NP	an independent phenotypic group	33173
@NP	both control and SCT animals	33221
@NP	The squares	33251
@NP	the Mahalanobis distances	33266
@NP	pairs of groups indicative of the relative phenotypic divergences	33300
@NP	pairs	33300
@NP	groups indicative of the relative phenotypic divergences	33309
@NP	groups	33309
@NP	the relative phenotypic divergences	33330
@NP	the P values	33394
@NP	the statistical significance of the comparisons between pairs of groups	33411
@NP	the statistical significance	33411
@NP	the comparisons between pairs of groups	33443
@NP	the comparisons	33443
@NP	pairs of groups	33467
@NP	pairs	33467
@NP	groups	33476
@NP	Figure 6 .	33485
@NP	Figure	33485
@NP	6	33492
@NP	Correlation	33495
@NP	data from behaviourally	33510
@NP	data	33510
@NP	functional recovery and expression	33541
@NP	selected phenotypic markers of SOL muscle Muscles	33579
@NP	selected phenotypic markers	33579
@NP	SOL muscle Muscles	33610
@NP	anaesthetized animals	33648
@NP	1 month	33670
@NP	the last test of functional recovery	33684
@NP	the last test	33684
@NP	functional recovery	33701
@NP	8 months	33733
@NP	the intervention for SCT and OEG transplantation	33748
@NP	the intervention	33748
@NP	SCT and OEG transplantation	33769
@NP	behavioural tests -LRB- contact placing , C	33814
@NP	behavioural tests	33814
@NP	contact placing	33833
@NP	C	33850
@NP	proprioceptive , P , responses -RRB-	33857
@NP	proprioceptive	33857
@NP	P	33873
@NP	responses	33876
@NP	3 , 5 and 7	33897
@NP	months	33908
@NP	the intervention	33921
@NP	Ramon-Cueto et al. 2000	33963
@NP	Ramon-Cueto	33963
@NP	et al. 2000	33975
@NP	et al.	33975
@NP	2000	33982
@NP	B , L and R	33989
@NP	detection	34009
@NP	recovery in both , left or right hind limb -LRB- s -RRB- , respectively	34022
@NP	recovery in both , left	34022
@NP	recovery	34022
@NP	right hind limb -LRB- s -RRB- , respectively	34048
@NP	right hind limb -LRB- s -RRB-	34048
@NP	right hind limb	34048
@NP	B , percentage of type I fibres	34082
@NP	B	34082
@NP	percentage of type I fibres	34085
@NP	percentage	34085
@NP	type I fibres	34099
@NP	immunohistochemistry	34125
@NP	C , proportion of slow rMLC from the whole rMLC complement ,	34147
@NP	C	34147
@NP	proportion of slow rMLC from the whole rMLC complement	34150
@NP	proportion	34150
@NP	slow rMLC from the whole rMLC complement	34164
@NP	slow rMLC	34164
@NP	the whole rMLC complement	34179
@NP	densitometry of Coomassie blue-stained 2D electrophoretograms	34220
@NP	densitometry	34220
@NP	Coomassie blue-stained 2D electrophoretograms	34236
@NP	D , fraction of the less acidic isoelectric point variant -LRB- 2s -RRB-	34283
@NP	D , fraction	34283
@NP	D	34283
@NP	fraction	34286
@NP	the less acidic isoelectric point variant -LRB- 2s -RRB-	34298
@NP	the less acidic isoelectric point variant	34298
@NP	2s	34341
@NP	the slow rMLC isoform , obtained as in C.	34350
@NP	the slow rMLC isoform	34350
@NP	C.	34388
@NP	E	34391
@NP	glycerol-3-phosphate dehydrogenase activity	34399
@NP	GPDH	34444
@NP	quantitative histochemistry	34464
@NP	Data	34493
@NP	left and right hind limb muscles	34502
@NP	control	34538
@NP	C , sham-operated animals	34547
@NP	C	34547
@NP	sham-operated animals	34550
@NP	n = 8	34573
@NP	n	34573
@NP	= 8	34575
@NP	SCT-rats	34584
@NP	n	34594
@NP	11	34598
@NP	± S.D. of all animals of the group	34612
@NP	± S.D.	34612
@NP	all animals of the group	34622
@NP	all animals	34622
@NP	the group	34637
@NP	1 -- 9	34648
@NP	the individual muscles	34661
@NP	the group of rats with completely transected spinal cord	34687
@NP	the group	34687
@NP	rats with completely transected spinal cord	34700
@NP	rats	34700
@NP	completely transected spinal cord	34710
@NP	OEG transplants , ordered from best -LRB- 1 -RRB- to worst -LRB- 9 -RRB-	34758
@NP	OEG transplants	34758
@NP	best -LRB- 1 -RRB-	34788
@NP	best	34788
@NP	1	34794
@NP	worst -LRB- 9 -RRB-	34800
@NP	worst	34800
@NP	9	34807
@NP	previously published scores	34833
@NP	functional tests -LRB- Ramon-Cueto et al. 2000 -RRB-	34866
@NP	functional tests	34866
@NP	Ramon-Cueto	34884
@NP	et al. 2000	34896
@NP	et al.	34896
@NP	2000	34903
@NP	A is a modification of Fig.	34910
@NP	is a modification	34912
@NP	a modification	34915
@NP	1	34938
@NP	the above-mentioned reference	34945
@NP	The correlations of these parameters with the scores of functional capacity	34976
@NP	The correlations	34976
@NP	these parameters with the scores of functional capacity	34996
@NP	these parameters	34996
@NP	the scores of functional capacity	35018
@NP	the scores	35018
@NP	functional capacity	35032
@NP	means of behavioural tests	35068
@NP	means	35068
@NP	behavioural tests	35077
@NP	the statistical significance of the observation	35124
@NP	the statistical significance	35124
@NP	the observation	35156
@NP	Muscle mass	35174
@NP	muscle-somatic index -LRB- MSI -RRB-	35187
@NP	muscle-somatic index	35187
@NP	MSI	35209
@NP	fibre cross-sectional area -LRB- CSA -RRB-	35218
@NP	fibre cross-sectional area	35218
@NP	CSA	35246
@NP	paralysed rat SOL and EDL muscles	35254
@NP	8 months	35288
@NP	SCT	35303
@NP	effect of OEG transplantation	35308
@NP	effect	35308
@NP	OEG transplantation	35318
@NP	Eight months	35338
@NP	a complete spinal cord transection -LRB- SCT -RRB-	35357
@NP	a complete spinal cord transection	35357
@NP	SCT	35393
@NP	the wet weights of paralysed rat SOL and EDL muscles	35399
@NP	the wet weights	35399
@NP	paralysed rat SOL and EDL muscles	35418
@NP	56 % and 76 % of the control values , respectively -LRB- Fig. 1 -RRB-	35468
@NP	56 % and 76 % of the control values , respectively	35468
@NP	56 % and 76 %	35468
@NP	the control values	35483
@NP	Fig. 1	35517
@NP	The MSI -LRB- wet weight referred to bodyweight -RRB-	35526
@NP	The MSI	35526
@NP	wet weight referred to bodyweight	35535
@NP	wet weight	35535
@NP	bodyweight	35558
@NP	to66 % and 82 % , respectively , and the mean fibre CSA	35582
@NP	to66 % and 82 % , respectively	35582
@NP	to66 %	35582
@NP	82 % , respectively	35591
@NP	82 %	35591
@NP	the mean fibre CSA	35614
@NP	the mean fibre	35614
@NP	CSA	35629
@NP	41 % and 58 %	35636
@NP	quantitative terms	35672
@NP	atrophy	35692
@NP	the soleus muscle	35709
@NP	slow-twitch fibres	35745
@NP	a higher diameter , more than the EDL	35769
@NP	a higher diameter	35769
@NP	more than the EDL	35788
@NP	more	35788
@NP	the EDL	35798
@NP	fast-twitch fibres	35829
@NP	animals transplanted with OEG immediately after SCT	35852
@NP	animals	35852
@NP	OEG	35878
@NP	SCT	35900
@NP	the mean wet muscle weight and fibre CSA	35905
@NP	non-transplanted animals	35974
@NP	differences	36007
@NP	statistical significance	36033
@NP	Both parameters	36059
@NP	transplanted animals than in sham-operated controls -LRB- P < 0.05 -RRB-	36103
@NP	transplanted animals	36103
@NP	sham-operated controls -LRB- P < 0.05 -RRB-	36132
@NP	sham-operated controls	36132
@NP	P < 0.05	36156
@NP	P	36156
@NP	< 0.05	36158
@NP	<	36158
@NP	0.05	36159
@NP	The MSI of the EDL , however ,	36166
@NP	The MSI of the EDL	36166
@NP	The MSI	36166
@NP	the EDL	36177
@NP	OEG-transplanted animals	36208
@NP	values	36245
@NP	controls	36281
@NP	non-transplanted SCT-animals	36322
@NP	Metabolic activity	36352
@NP	paralysed rat soleus and EDL muscles 8 months after complete SCT	36374
@NP	paralysed rat soleus and EDL muscles	36374
@NP	8 months	36411
@NP	complete SCT	36426
@NP	effect	36440
@NP	OEG transplantation Cordotomy	36450
@NP	a marked effect	36484
@NP	the metabolic properties of both skeletal muscle types	36503
@NP	the metabolic properties	36503
@NP	both skeletal muscle types	36531
@NP	the soleus -LRB- Fig. 2 -RRB-	36575
@NP	the soleus	36575
@NP	Fig. 2	36587
@NP	The mean	36596
@NP	histochemical glycolytic capacity of	36605
@NP	histochemical glycolytic capacity	36605
@NP	muscle types	36647
@NP	the indirect marker glycerol 3-phosphate dehydrogenase -LRB- GPDH -RRB-	36674
@NP	the indirect marker glycerol 3-phosphate dehydrogenase	36674
@NP	GPDH	36730
@NP	150 % -LRB- P < 0.0001 -RRB- and 117 % -LRB- P < 0.0001 -RRB-	36750
@NP	150 %	36750
@NP	P < 0.0001	36756
@NP	P	36756
@NP	< 0.0001	36758
@NP	<	36758
@NP	0.0001	36759
@NP	117 %	36771
@NP	P < 0.0001	36777
@NP	P	36777
@NP	< 0.0001	36779
@NP	<	36779
@NP	0.0001	36780
@NP	soleus and EDL muscle	36792
@NP	soleus muscle	36832
@NP	transplantation of OEG	36847
@NP	transplantation	36847
@NP	OEG	36866
@NP	the GPDH activity	36878
@NP	respect	36915
@NP	non-transplanted animals -LRB- P < 0.0001 -RRB-	36926
@NP	non-transplanted animals	36926
@NP	P < 0.0001	36952
@NP	P	36952
@NP	< 0.0001	36954
@NP	<	36954
@NP	0.0001	36955
@NP	higher -LRB- P < 0.0001 -RRB- than controls	36979
@NP	higher -LRB- P < 0.0001 -RRB-	36979
@NP	P < 0.0001	36987
@NP	P	36987
@NP	< 0.0001	36989
@NP	<	36989
@NP	0.0001	36990
@NP	controls	37003
@NP	the EDL muscle of OEG-transplanted animals	37031
@NP	the EDL muscle	37031
@NP	OEG-transplanted animals	37049
@NP	GPDH levels	37074
@NP	non-transplanted animals	37105
@NP	P < 0.0001	37131
@NP	P	37131
@NP	< 0.0001	37133
@NP	<	37133
@NP	0.0001	37134
@NP	controls -LRB- Fig. 2 -RRB-	37179
@NP	controls	37179
@NP	Fig. 2	37189
@NP	OEG transplantation	37204
@NP	the glycolytic activity of the EDL to control values	37251
@NP	the glycolytic activity	37251
@NP	the EDL to control values	37278
@NP	values	37297
@NP	Themuscle oxidative capacity , measured by quantitative SDH histochemistry ,	37305
@NP	Themuscle oxidative capacity	37305
@NP	quantitative SDH histochemistry	37347
@NP	the soleus	37402
@NP	the EDL of cordotomized animals	37429
@NP	the EDL	37429
@NP	cordotomized animals	37440
@NP	controls but differences	37479
@NP	statistical significance -LRB- Fig. 2 -RRB-	37518
@NP	statistical significance	37518
@NP	Fig. 2	37544
@NP	an apparent paradox	37556
@NP	the EDL muscle of OEG-transplanted animals	37580
@NP	the EDL muscle	37580
@NP	OEG-transplanted animals	37598
@NP	the mean oxidative capacity	37623
@NP	non-transplanted animals	37674
@NP	values that were statistically different from both	37709
@NP	values	37709
@NP	control and non-transplanted animals -LRB- Fig. 2 -RRB-	37761
@NP	control and non-transplanted animals	37761
@NP	Fig. 2	37799
@NP	Expression	37808
@NP	isoforms of the myosin heavy -LRB- MHC -RRB-	37822
@NP	isoforms	37822
@NP	the myosin heavy -LRB- MHC -RRB-	37834
@NP	the myosin heavy	37834
@NP	MHC	37852
@NP	light chains -LRB- MLC -RRB-	37861
@NP	light chains	37861
@NP	MLC	37875
@NP	paralysed rat soleus and EDL muscles 8 months after SCT	37883
@NP	paralysed rat soleus and EDL muscles	37883
@NP	8 months	37920
@NP	SCT	37935
@NP	effect of OEG transplants SCT	37940
@NP	effect	37940
@NP	OEG transplants SCT	37950
@NP	a slow-to-fast fibre type switching	37978
@NP	muscle types	38022
@NP	the soleus	38039
@NP	slow-twitch fibres	38075
@NP	its transition	38094
@NP	that of the EDL	38131
@NP	that	38131
@NP	the EDL	38139
@NP	fast-twitch fibres -LRB- Fig. 3 -RRB-	38165
@NP	fast-twitch fibres	38165
@NP	Fig. 3	38185
@NP	Eight months	38194
@NP	cordotomy	38213
@NP	the EDL muscle	38224
@NP	a reduced proportion	38246
@NP	fibres	38270
@NP	the MHC isotypes	38288
@NP	I -LRB- β/slow -RRB- or IIA	38305
@NP	I -LRB- β/slow -RRB-	38305
@NP	IIA	38319
@NP	controls , while hybrid IID/XB fibres increased	38338
@NP	controls	38338
@NP	hybrid IID/XB fibres	38354
@NP	Transplantation of OEG immediately after SCT	38386
@NP	Transplantation	38386
@NP	OEG immediately after SCT	38405
@NP	OEG	38405
@NP	SCT	38427
@NP	no significant effect on fibre type distribution in the EDL muscle	38435
@NP	no significant effect	38435
@NP	fibre type distribution in the EDL muscle	38460
@NP	fibre type distribution	38460
@NP	the EDL muscle	38487
@NP	the proportion of IID/X fibres	38507
@NP	the proportion	38507
@NP	IID/X fibres	38525
@NP	the paralysed soleus	38561
@NP	8 months after SCT , the proportion of fibres expressing MHC-I	38583
@NP	8 months	38583
@NP	SCT , the proportion of fibres expressing MHC-I	38597
@NP	SCT	38597
@NP	the proportion of fibres expressing MHC-I	38602
@NP	the proportion	38602
@NP	fibres expressing MHC-I	38620
@NP	fibres	38620
@NP	MHC-I	38638
@NP	fibres expressing MHC-IIA or IID/X , either alone	38675
@NP	fibres	38675
@NP	MHC-IIA or IID/X	38693
@NP	combination increased -LRB- see Fig. 3 -RRB-	38730
@NP	combination	38730
@NP	Fig. 3	38757
@NP	OEG transplantation the proportion of type	38776
@NP	OEG transplantation	38776
@NP	the proportion of type	38796
@NP	the proportion	38796
@NP	type	38814
@NP	I fibres in the soleus	38819
@NP	I fibres	38819
@NP	the soleus	38831
@NP	non-transplanted and control animals	38867
@NP	both	38938
@NP	The proportion of type I+IIA fibres	38944
@NP	The proportion	38944
@NP	type I+IIA fibres	38962
@NP	non-transplanted animals	39007
@NP	themnor fromcontrols	39063
@NP	The highstandarddeviation of the means	39085
@NP	The highstandarddeviation	39085
@NP	the means	39114
@NP	particularly the fraction of type I fibres	39129
@NP	particularly the fraction	39129
@NP	type I fibres	39158
@NP	the SOL of OEG-transplanted animals	39175
@NP	the SOL	39175
@NP	OEG-transplanted animals	39186
@NP	a high degree of variability in the individual responses	39229
@NP	a high degree	39229
@NP	variability in the individual responses	39246
@NP	variability	39246
@NP	the individual responses	39261
@NP	most of the parameters tested	39300
@NP	most	39300
@NP	the parameters tested	39308
@NP	the parameters	39308
@NP	no significant differences	39330
@NP	contralateralmuscles	39379
@NP	the fibre type distribution in the EDL muscle of OEG-transplanted rats	39400
@NP	the fibre type distribution	39400
@NP	the EDL muscle of OEG-transplanted rats	39431
@NP	the EDL muscle	39431
@NP	OEG-transplanted rats	39449
@NP	an exception	39475
@NP	the relative abundance of IIAD/X and IID/X fibres	39494
@NP	the relative abundance	39494
@NP	IIAD/X and IID/X fibres	39520
@NP	P < 0.05 and P < 0.001 , respectively	39556
@NP	P < 0.05	39556
@NP	P <	39556
@NP	P	39556
@NP	0.05	39559
@NP	P < 0.001 , respectively	39568
@NP	P	39568
@NP	< 0.001 , respectively	39570
@NP	<	39570
@NP	0.001	39571
@NP	that of type IIB fibres	39598
@NP	that	39598
@NP	type IIB fibres	39606
@NP	P < 0.05	39633
@NP	P	39633
@NP	< 0.05	39635
@NP	<	39635
@NP	0.05	39636
@NP	right hind limb muscles	39667
@NP	Spinal cord transection	39692
@NP	a marked effect on the expression of myosin light chain -LRB- MLC -RRB- isoforms	39725
@NP	a marked effect	39725
@NP	the expression of myosin light chain -LRB- MLC -RRB- isoforms	39744
@NP	the expression	39744
@NP	myosin light chain -LRB- MLC -RRB- isoforms	39762
@NP	Eight months	39797
@NP	SCT	39816
@NP	the proportion	39821
@NP	slow -LRB- s -RRB- isoforms	39839
@NP	both essential -LRB- e -RRB- and regulatory -LRB- r -RRB- MLCs	39860
@NP	e	39876
@NP	r	39895
@NP	paralysed SOL or EDL muscles	39906
@NP	controls -LRB- Fig. 4a and b panels -RRB-	39953
@NP	controls	39953
@NP	Fig. 4a and b panels	39963
@NP	Fig. 4a	39963
@NP	b panels	39975
@NP	This effect	39986
@NP	the SOL -LRB- Fig. 4 , upper half -RRB-	40035
@NP	the SOL	40035
@NP	Fig. 4	40044
@NP	upper half	40052
@NP	the proportion	40071
@NP	slow isoforms of rMLCs -LRB- denoted 2s in 2D patterns of Fig. 4 -RRB-	40089
@NP	slow isoforms	40089
@NP	rMLCs	40106
@NP	2s	40121
@NP	2D patterns of Fig. 4	40127
@NP	2D patterns	40127
@NP	Fig. 4	40142
@NP	less than one fifth of control	40165
@NP	less than one fifth	40165
@NP	control	40188
@NP	the proportion	40221
@NP	MLC isoforms in the EDL muscle -LRB- Fig. 4 , bottom half -RRB-	40239
@NP	MLC isoforms	40239
@NP	the EDL muscle -LRB- Fig. 4 , bottom half -RRB-	40255
@NP	the EDL muscle	40255
@NP	Fig. 4	40271
@NP	bottom half	40279
@NP	Transplantation of OEG	40293
@NP	Transplantation	40293
@NP	OEG	40312
@NP	the proportion of slow MLC isoforms	40335
@NP	the proportion	40335
@NP	slow MLC isoforms	40353
@NP	non-transplanted animals	40388
@NP	differences	40417
@NP	statistical significance -LRB- Fig. 4a and b panels -RRB-	40443
@NP	statistical significance	40443
@NP	Fig. 4a and b panels	40469
@NP	Fig. 4a	40469
@NP	b panels	40481
@NP	Gonzalez et al. 2002 and depicted in Fig. 4 , 2D patterns	40517
@NP	Gonzalez	40517
@NP	et al. 2002 and	40526
@NP	et al.	40526
@NP	2002 and	40533
@NP	Fig. 4 , 2D patterns	40554
@NP	Fig. 4	40554
@NP	2D patterns	40562
@NP	both	40576
@NP	and	40590
@NP	-LRB- s -RRB- rMLC isoforms	40599
@NP	-LRB- s -RRB-	40599
@NP	rMLC isoforms	40603
@NP	different variants	40627
@NP	the same molecular weight	40651
@NP	slightly different	40681
@NP	SOL	40722
@NP	the proportion of variant 2s	40727
@NP	the proportion	40727
@NP	variant 2s	40745
@NP	the less acidic	40757
@NP	the variants of the slow rMLC isoform	40776
@NP	the variants	40776
@NP	the slow rMLC isoform	40792
@NP	the most abundantly represented in thismuscle	40818
@NP	the most abundantly represented	40818
@NP	thismuscle	40853
@NP	cordotomy	40895
@NP	This variant	40906
@NP	EDL muscle	40939
@NP	a minor component of the minor -LRB- slow -RRB- isoform	40954
@NP	a minor component	40954
@NP	the minor -LRB- slow -RRB- isoform	40975
@NP	its proportion	41005
@NP	SCT animals	41040
@NP	a statistically significant manner	41055
@NP	Transplantation of OEG	41091
@NP	Transplantation	41091
@NP	OEG	41110
@NP	the proportion of variant 2s	41141
@NP	the proportion	41141
@NP	variant 2s	41159
@NP	the EDL	41173
@NP	the control level	41184
@NP	the SOL	41215
@NP	OEG transplantation	41224
@NP	the proportion of this variant	41254
@NP	the proportion	41254
@NP	this variant	41272
@NP	a level	41288
@NP	both control and non-transplanted animals	41338
@NP	both control	41338
@NP	non-transplanted animals	41355
@NP	The high standard deviation of the data from OEG-transplanted animals	41381
@NP	The high standard deviation	41381
@NP	the data from OEG-transplanted animals	41412
@NP	the data	41412
@NP	OEG-transplanted animals	41426
@NP	a wide range of variation	41469
@NP	a wide range	41469
@NP	variation	41485
@NP	the individual responses	41498
@NP	Global analysis	41524
@NP	slow - and fast-twitch skeletal muscles	41543
@NP	cordotomized rats	41585
@NP	OEG transplantation	41613
@NP	expression of phenotypic markers	41642
@NP	expression	41642
@NP	phenotypic markers	41656
@NP	the degree	41688
@NP	similarity between muscles of OEG-transplanted and those of control	41702
@NP	similarity	41702
@NP	muscles of OEG-transplanted and those of control	41721
@NP	muscles of OEG-transplanted	41721
@NP	muscles	41721
@NP	OEG-transplanted	41732
@NP	those of control	41753
@NP	those	41753
@NP	control	41762
@NP	non-transplanted cordotomized animals , a multivariate discriminant analysis	41774
@NP	non-transplanted cordotomized animals	41774
@NP	a multivariate discriminant analysis	41813
@NP	all the data	41869
@NP	each muscle	41896
@NP	left and right hind limbs as independent values	41919
@NP	left and right hind limbs	41919
@NP	independent values	41948
@NP	The discriminant model for the SOL	41968
@NP	The discriminant model	41968
@NP	the SOL	41995
@NP	the following variables	42012
@NP	wet weight	42037
@NP	muscle-somatic index	42049
@NP	percentage of type I	42071
@NP	percentage	42071
@NP	type I	42085
@NP	I+IIA	42093
@NP	IIA , IIAD/X and IIX fibres	42100
@NP	SDH and GPDH activities	42128
@NP	fibre CSA	42153
@NP	slow rMLC/total rMLC	42164
@NP	slow eMLC/total eMLC	42186
@NP	variant 2s/total rMLC	42208
@NP	variant 2s/slow rMLC	42231
@NP	variant 2f/total rMLC	42253
@NP	variant 2f/fast rMLC	42279
@NP	the EDL muscle	42305
@NP	the same parameters	42320
@NP	the fraction of type IID/XB and IIB fibres	42363
@NP	the fraction	42363
@NP	type IID/XB and IIB fibres	42379
@NP	that of type I and IIA	42430
@NP	that	42430
@NP	type I and IIA	42438
@NP	type I	42438
@NP	IIA	42449
@NP	these parameters	42459
@NP	the percentages of correctly classified observations	42477
@NP	the percentages	42477
@NP	correctly classified observations	42496
@NP	100 , 90.9	42535
@NP	100	42535
@NP	90.9	42540
@NP	77.8 and 89.3 in the SOL	42546
@NP	77.8 and 89.3	42546
@NP	the SOL	42563
@NP	100	42575
@NP	95.45	42580
@NP	94.43 and 96.42 in EDL muscle	42587
@NP	94.43 and 96.42	42587
@NP	EDL muscle	42606
@NP	samples of control	42622
@NP	samples	42622
@NP	control	42633
@NP	non-transplanted , OEG-transplanted and whole group of animals	42642
@NP	non-transplanted , OEG-transplanted and whole group	42642
@NP	animals	42696
@NP	None of the 44 individual skeletal muscles -LRB- soleus and EDL ,	42719
@NP	None	42719
@NP	the 44 individual skeletal muscles -LRB- soleus and EDL ,	42727
@NP	the 44 individual skeletal muscles	42727
@NP	soleus and EDL	42763
@NP	right hind limbs -RRB- from SCT , non-transplanted animals	42788
@NP	right hind limbs -RRB-	42788
@NP	SCT , non-transplanted animals	42811
@NP	SCT	42811
@NP	non-transplanted animals	42816
@NP	characteristics	42851
@NP	control animal muscle	42870
@NP	only 3	42897
@NP	OEG-transplanted animals	42944
@NP	OEG-transplanted rats 31 out of 36	42974
@NP	OEG-transplanted rats	42974
@NP	31	42996
@NP	36	43006
@NP	muscles	43009
@NP	4 as deriving from SCT and only 1 from control animals	43044
@NP	4	43044
@NP	SCT and only 1 from control animals	43063
@NP	SCT	43063
@NP	only 1 from control animals	43071
@NP	only 1	43071
@NP	control animals	43083
@NP	a per muscle type basis , contrary to expected	43103
@NP	a per muscle type basis , contrary to	43103
@NP	a per muscle type	43103
@NP	basis	43121
@NP	the percentage of correctly classified observations in the EDL	43150
@NP	the percentage	43150
@NP	correctly classified observations in the EDL	43168
@NP	correctly classified observations	43168
@NP	the EDL	43205
@NP	the SOL	43238
@NP	The Mahalanobis distances	43247
@NP	group pairs and their statistical significance	43281
@NP	group pairs	43281
@NP	their statistical significance	43297
@NP	muscle types	43336
@NP	Fig. 5	43366
@NP	The data	43374
@NP	the differences	43393
@NP	the overall phenotypic characteristics	43417
@NP	muscles of OEG-transplanted animals	43459
@NP	muscles	43459
@NP	OEG-transplanted animals	43470
@NP	those of both control and non-transplanted	43499
@NP	those	43499
@NP	both control and non-transplanted	43508
@NP	both control	43508
@NP	non-transplanted	43525
@NP	respect to skeletal muscle phenotype	43554
@NP	respect	43554
@NP	skeletal muscle phenotype	43565
@NP	OEG-transplanted rats	43592
@NP	a separate group	43620
@NP	control and non-transplanted	43655
@NP	overall properties	43690
@NP	non-transplanted animals	43725
@NP	controls	43758
@NP	their relative Mahalanobis distances	43783
@NP	Correlation	43821
@NP	previously published data	43836
@NP	functional tests	43867
@NP	the expression	43889
@NP	morphological , metabolic and contractile activity markers	43907
@NP	fast - and slow-twitch skeletal muscle	43968
@NP	cordotomized rats	44009
@NP	OEG transplantation	44037
@NP	general terms	44060
@NP	practically all the phenotypic markers	44075
@NP	this investigation for SOL	44126
@NP	this investigation	44126
@NP	SOL	44149
@NP	EDL muscles	44156
@NP	previously published data	44194
@NP	functional capacity	44225
@NP	frombehavioural tests	44253
@NP	0 to 4	44288
@NP	Ramon-Cueto	44322
@NP	et al. 2000	44334
@NP	et al.	44334
@NP	2000	44341
@NP	Figure 6	45638
@NP	mean values of these parameters	45662
@NP	mean values	45662
@NP	these parameters	45677
@NP	control -LRB- C -RRB-	45697
@NP	control	45697
@NP	C	45706
@NP	SCT	45724
@NP	hind limb SOL	45744
@NP	the individual values	45772
@NP	left and right SOL	45807
@NP	each	45829
@NP	the OEG-transplanted animals	45837
@NP	1 to 9	45880
@NP	previously reported time	45900
@NP	course and amplitude	45925
@NP	recovery	45949
@NP	sensory-motor functions -LRB- Ramon-Cueto et al. 2000 -RRB-	45961
@NP	sensory-motor functions	45961
@NP	Ramon-Cueto	45986
@NP	et al. 2000	45998
@NP	et al.	45998
@NP	2000	46005
@NP	Fig. 6A	46027
@NP	It	46036
@NP	this figure	46058
@NP	all four parameters	46075
@NP	a good discrimination betweenmuscles	46103
@NP	animals	46145
@NP	sensory and motor function	46168
@NP	the first 3 months	46202
@NP	the intervention	46226
@NP	those	46247
@NP	the first signs of recovery	46265
@NP	the first signs	46265
@NP	recovery	46284
@NP	the final part of the 8 month period	46296
@NP	the final part	46296
@NP	the 8 month period	46314
@NP	the data of Fig. 6	46338
@NP	the data	46338
@NP	Fig. 6	46350
@NP	it	46357
@NP	all four phenotypic markers	46376
@NP	rats	46415
@NP	1 , 2 and 3	46420
@NP	the animals	46434
@NP	skeletal muscle characteristics	46451
@NP	normal	46494
@NP	this order	46505
@NP	rat 9	46521
@NP	the farthest	46530
@NP	The remaining five animals	46544
@NP	slightly different positions	46587
@NP	a function of the parameter considered	46619
@NP	a function	46619
@NP	the parameter considered	46633
@NP	the parameter	46633
@NP	GPDH activity and the fraction of variant 2s from the slow rMLC isoform	46659
@NP	GPDH activity	46659
@NP	the fraction of variant 2s from the slow rMLC isoform	46677
@NP	the fraction	46677
@NP	variant 2s from the slow rMLC isoform	46693
@NP	variant 2s	46693
@NP	the slow rMLC isoform	46709
@NP	the only parameters	46736
@NP	enough sensitivity	46770
@NP	animals with similar motor functional capacity	46798
@NP	animals with similar motor	46798
@NP	animals	46798
@NP	similar motor	46811
@NP	expression of a molecular marker	46871
@NP	expression	46871
@NP	a molecular marker	46885
@NP	a mean between both hind limb muscles	46917
@NP	a mean	46917
@NP	both hind limb muscles	46932
@NP	both parameters	46956
@NP	OEG-transplanted animals	46980
@NP	the sequence	47022
@NP	1 , 2 , 3 , 4 -LRB- 6 -RRB- , 6 -LRB- 4 -RRB- , 8 , 7 , 5 , 9	47035
@NP	1	47035
@NP	2	47038
@NP	3	47041
@NP	4 -LRB- 6 -RRB-	47044
@NP	4	47044
@NP	6	47046
@NP	6 -LRB- 4 -RRB-	47050
@NP	6	47050
@NP	4	47052
@NP	8	47056
@NP	7	47059
@NP	5	47062
@NP	9	47065
@NP	Similar conclusions	47068
@NP	the analysis	47106
@NP	almost the same parameters in the EDL muscle -LRB- not shown -RRB-	47122
@NP	almost the same parameters	47122
@NP	the EDL muscle	47152
@NP	this muscle	47184
@NP	GPDH activity -LRB- Spearman 's correlation r = − 0.604 , P < 0.0001 -RRB-	47197
@NP	GPDH activity	47197
@NP	Spearman 's correlation r = − 0.604 , P	47212
@NP	Spearman 's correlation r	47212
@NP	Spearman 's	47212
@NP	− 0.604 , P	47238
@NP	− 0.604	47238
@NP	P	47246
@NP	0.0001	47249
@NP	wet muscle weight -LRB- Pearson 's correlation r = 0.613 , P < 0.0001 -RRB-	47261
@NP	wet muscle weight	47261
@NP	Pearson 's correlation r = 0.613 , P	47280
@NP	Pearson 's correlation r	47280
@NP	Pearson 's	47280
@NP	0.613 , P	47305
@NP	0.613	47305
@NP	P	47312
@NP	0.0001	47315
@NP	the highest discriminatory potential	47356
@NP	Discussion The present investigation	47395
@NP	Discussion	47395
@NP	The present investigation	47406
@NP	our knowledge the first study	47438
@NP	our knowledge	47438
@NP	the first study	47452
@NP	the impact of OEG transplantation	47479
@NP	the impact	47479
@NP	OEG transplantation	47493
@NP	spinal cord	47540
@NP	the phenotypic characteristics of fast - and slow-twitch hind limb	47555
@NP	the phenotypic characteristics	47555
@NP	fast - and slow-twitch hind limb	47589
@NP	a variety of phenotypic markers	47649
@NP	a variety	47649
@NP	phenotypic markers	47662
@NP	possible correlations	47694
@NP	the relative maintenance of normal muscle characteristics	47724
@NP	the relative maintenance	47724
@NP	normal muscle characteristics	47752
@NP	the functional capacity for locomotion derived from behavioural tests	47786
@NP	the functional capacity	47786
@NP	locomotion derived from behavioural tests	47814
@NP	locomotion	47814
@NP	behavioural tests	47838
@NP	The main findings of this study	47857
@NP	The main findings	47857
@NP	this study	47878
@NP	-LRB- a -RRB- transplantation of OEG into the transected rat spinal cord	47898
@NP	-LRB- a -RRB- transplantation of OEG	47898
@NP	transplantation	47902
@NP	OEG	47921
@NP	the transected rat spinal cord	47930
@NP	hind limb	47972
@NP	skeletal muscle phenotypes	47982
@NP	paralysed and control	48049
@NP	paralysed	48049
@NP	control	48063
@NP	the expression levels	48109
@NP	a variety of phenotypic markers of slowand fast-twitch hind limb	48134
@NP	a variety	48134
@NP	phenotypic markers of slowand fast-twitch hind limb	48147
@NP	phenotypic markers	48147
@NP	slowand fast-twitch hind limb	48169
@NP	skeletal muscle	48199
@NP	the sensory-motor	48240
@NP	capacity of SCT , OEG-transplanted rats determined by means of behavioural tests	48269
@NP	capacity of SCT	48269
@NP	capacity	48269
@NP	SCT	48281
@NP	OEG-transplanted rats determined by means of behavioural tests	48286
@NP	OEG-transplanted rats	48286
@NP	means of behavioural tests	48322
@NP	means	48322
@NP	behavioural tests	48331
@NP	all parameters tested	48356
@NP	all parameters	48356
@NP	the histochemical glycerol-3-phosphate dehydrogenase activity	48379
@NP	the fraction	48445
@NP	the less acidic variant -LRB- variant 2s -RRB-	48461
@NP	the less acidic variant	48461
@NP	variant 2s	48486
@NP	the slow rMLC isoform , in SOL muscle ,	48501
@NP	the slow rMLC isoform	48501
@NP	SOL muscle	48527
@NP	the most sensitive phenotypic marker	48552
@NP	the degree	48601
@NP	a SOLmuscle	48617
@NP	normal characteristics following SCT and OEG transplantation	48640
@NP	normal characteristics	48640
@NP	SCT and OEG transplantation	48673
@NP	histochemicalGPDHactivity andmuscleweight -LRB- ormuscle-somatic index -RRB-	48713
@NP	histochemicalGPDHactivity andmuscleweight	48713
@NP	ormuscle-somatic index	48756
@NP	the most sensitive markers in EDL muscle	48784
@NP	the most sensitive markers	48784
@NP	EDL muscle	48814
@NP	It	48826
@NP	this study	48848
@NP	components of the contractile machinery	48879
@NP	components	48879
@NP	the contractile machinery	48893
@NP	sensitive markers	48922
@NP	changes in slow - and fast-twitch skeletal muscle phenotypes in response	48943
@NP	changes	48943
@NP	slow - and fast-twitch skeletal muscle phenotypes in response	48954
@NP	slow - and fast-twitch skeletal muscle phenotypes	48954
@NP	response	49006
@NP	SCT and OEG transplantation	49018
@NP	components of the energy metabolism and muscle mass	49056
@NP	components	49056
@NP	the energy metabolism and muscle mass	49070
@NP	The multivariate analysis	49109
@NP	this study	49148
@NP	diverse markers	49165
@NP	skeletal muscle morphology , metabolism and molecular diversity	49184
@NP	myosin subunits	49250
@NP	fast - and slow-twitch skeletal muscle phenotypes	49289
@NP	SCT , OEG-transplanted animals	49341
@NP	SCT	49341
@NP	OEG-transplanted animals	49346
@NP	those of non-transplanted	49391
@NP	those	49391
@NP	non-transplanted	49400
@NP	controls	49426
@NP	account	49448
@NP	the high percentage	49456
@NP	correctly classified observations obtained in this analysis	49479
@NP	correctly classified observations	49479
@NP	this analysis	49525
@NP	this result	49540
@NP	solid evidence of the impact of OEG transplantation	49561
@NP	solid evidence	49561
@NP	the impact of OEG transplantation	49579
@NP	the impact	49579
@NP	OEG transplantation	49593
@NP	maintenance of skeletal muscle properties	49616
@NP	maintenance	49616
@NP	skeletal muscle properties	49631
@NP	quantitative terms	49662
@NP	the degree	49691
@NP	type-specific protein expression	49717
@NP	hind limb skeletalmuscle of OEG-transplanted rats	49753
@NP	hind limb skeletalmuscle	49753
@NP	OEG-transplanted rats	49781
@NP	normality	49814
@NP	variable fromone animal tothe other	49835
@NP	It	49872
@NP	3	49903
@NP	9 OEG-transplanted animals	49912
@NP	The remaining 6 animals	49940
@NP	precisely those	49965
@NP	loss of sensory-motor function	49993
@NP	loss	49993
@NP	sensory-motor function	50001
@NP	3 months	50024
@NP	the intervention	50038
@NP	muscle phenotypes	50063
@NP	normal individuals	50118
@NP	the expression of fibre type-specific characteristics	50137
@NP	the expression	50137
@NP	fibre type-specific characteristics	50155
@NP	proper activation	50204
@NP	slow and fast motor neurons	50225
@NP	Schiaffino & Reggiani , 1996 ; Pette & Staron , 2001	50254
@NP	Schiaffino & Reggiani	50254
@NP	1996 ; Pette & Staron	50277
@NP	1996	50277
@NP	Pette & Staron	50283
@NP	2001	50299
@NP	a possible interpretation of these data	50306
@NP	a possible interpretation	50306
@NP	these data	50335
@NP	3	50357
@NP	9 animals	50366
@NP	OEG transplantation	50376
@NP	a functional connectivity of local spinal circuits	50420
@NP	a functional connectivity	50420
@NP	local spinal circuits	50449
@NP	motor pathways	50486
@NP	a previous study	50505
@NP	the same rats used in this investigation -LRB- Ramon-Cueto et al. 2000 -RRB-	50532
@NP	the same rats	50532
@NP	this investigation -LRB- Ramon-Cueto et al. 2000 -RRB-	50554
@NP	this investigation	50554
@NP	Ramon-Cueto et al. 2000	50574
@NP	Ramon-Cueto	50574
@NP	et al. 2000	50586
@NP	et al.	50586
@NP	2000	50593
@NP	long distance regeneration	50600
@NP	motor pathways within caudal cord stumps and functional recovery	50630
@NP	motor pathways	50630
@NP	caudal cord stumps and functional recovery	50652
@NP	caudal cord stumps	50652
@NP	functional recovery	50675
@NP	this investigation	50712
@NP	it	50731
@NP	the regenerated axons	50761
@NP	functional connections	50795
@NP	addition	50822
@NP	it	50832
@NP	these connections , in the cases that they were formed ,	50852
@NP	these connections	50852
@NP	the cases that they were formed	50874
@NP	the cases	50874
@NP	they	50889
@NP	normal	50917
@NP	appropriate activity patterns	50942
@NP	An additional mechanism	50984
@NP	OEG transplants	51012
@NP	a relative maintenance of skeletal muscle characteristics	51039
@NP	a relative maintenance	51039
@NP	skeletal muscle characteristics	51065
@NP	apparent functional recovery	51101
@NP	compensatory adaptations	51144
@NP	increased neuromuscular activity and motor automatism	51180
@NP	upper motor neuron pathways	51246
@NP	the motor cortex	51277
@NP	a main influence	51300
@NP	local spinal circuits -LRB- central pattern generators -RRB-	51320
@NP	local spinal circuits	51320
@NP	central pattern generators	51343
@NP	the coordinated movements associated with locomotion	51384
@NP	the coordinated movements	51384
@NP	locomotion	51426
@NP	Automaticity of movement	51438
@NP	Automaticity	51438
@NP	movement	51454
@NP	sensory information	51481
@NP	movement	51514
@NP	the only input to control central pattern generation in SCI individuals	51538
@NP	central pattern generation in SCI individuals	51564
@NP	central pattern generation	51564
@NP	SCI individuals	51594
@NP	months after SCI	51631
@NP	months	51631
@NP	SCI	51644
@NP	the spinal cord circuitry	51649
@NP	functional characteristics	51697
@NP	it	51744
@NP	some	51754
@NP	those spinal pathways	51762
@NP	Edgerton et al. 2006 ; Wolpaw , 2007	51812
@NP	Edgerton	51812
@NP	et al. 2006 ; Wolpaw , 2007	51821
@NP	et al. 2006	51821
@NP	et al.	51821
@NP	2006	51828
@NP	Wolpaw , 2007	51834
@NP	Wolpaw	51834
@NP	2007	51842
@NP	the functional recovery observed in these animals	51870
@NP	the functional recovery	51870
@NP	these animals	51906
@NP	The rationale for using OEG in regenerative studies of the SC	51921
@NP	The rationale	51921
@NP	OEG	51945
@NP	regenerative studies of the SC	51952
@NP	regenerative studies	51952
@NP	the SC	51976
@NP	local inhibitory influences	52019
@NP	axon growth	52051
@NP	glial pathways	52077
@NP	neurotrophic factors which stimulate neuronal gene expression and axonal growth	52104
@NP	neurotrophic factors	52104
@NP	neuronal gene expression and axonal growth	52141
@NP	neuronal gene expression	52141
@NP	axonal growth	52170
@NP	OEG	52185
@NP	nerve growth factor	52218
@NP	NGF	52239
@NP	neurotrophin -LRB- NF -RRB- 4/5	52245
@NP	neurotrophin	52245
@NP	NF	52259
@NP	4/5	52263
@NP	neuroregulin	52268
@NP	brain-derived neurotrophic factor -LRB- BDNF -RRB-	52282
@NP	brain-derived neurotrophic factor	52282
@NP	BDNF	52317
@NP	NT-3 -LRB- Ramon-Cueto & Avila , 1998 ; Boruch et al. 2001 -RRB-	52327
@NP	NT-3	52327
@NP	Ramon-Cueto & Avila , 1998 ; Boruch et al. 2001	52333
@NP	Ramon-Cueto & Avila , 1998 ; Boruch et al.	52333
@NP	Ramon-Cueto & Avila , 1998	52333
@NP	Ramon-Cueto & Avila	52333
@NP	1998	52354
@NP	Boruch et al.	52360
@NP	Boruch	52360
@NP	et al.	52367
@NP	2001	52374
@NP	some of them	52396
@NP	some	52396
@NP	them	52404
@NP	considerable amounts	52412
@NP	addition	52437
@NP	the migratory pattern of OEG	52447
@NP	the migratory pattern	52447
@NP	OEG	52472
@NP	these cells	52490
@NP	external stimuli	52522
@NP	injured nerve cells and their processes -LRB- Boruch et al. 2001 -RRB-	52556
@NP	injured nerve cells	52556
@NP	their processes -LRB- Boruch et al. 2001 -RRB-	52580
@NP	their processes	52580
@NP	Boruch	52597
@NP	et al. 2001	52604
@NP	et al.	52604
@NP	2001	52611
@NP	Slow skeletal muscle fibres	52618
@NP	NT-4	52681
@NP	an activity-dependent manner	52689
@NP	growth and remodelling	52733
@NP	adult motoneuron innervation -LRB- Belluardo et al. 2001 -RRB-	52759
@NP	adult motoneuron innervation	52759
@NP	Belluardo	52789
@NP	et al. 2001	52799
@NP	et al.	52799
@NP	2001	52806
@NP	Hind limb muscle fibres and lumbar astrocytes	52813
@NP	Hind limb muscle fibres	52813
@NP	lumbar astrocytes	52841
@NP	HSP70	52886
@NP	a stress protein	52893
@NP	a neurotrohic factor critically involved	52933
@NP	a neurotrohic factor	52933
@NP	motoneuron survival -LRB- Robinson et al. 2005 -RRB-	52977
@NP	motoneuron survival	52977
@NP	Robinson	52998
@NP	et al. 2005	53007
@NP	et al.	53007
@NP	2005	53014
@NP	Exercise	53021
@NP	the regenerative potential of CNS neurons -LRB- Doyle & Roberts , 2006 -RRB-	53052
@NP	the regenerative potential	53052
@NP	CNS neurons -LRB- Doyle & Roberts , 2006 -RRB-	53082
@NP	CNS neurons	53082
@NP	Doyle & Roberts	53095
@NP	2006	53112
@NP	neurotrophic factor levels and synaptic plasticity -LRB- Ying et al. 2005 -RRB-	53127
@NP	neurotrophic factor levels	53127
@NP	synaptic plasticity -LRB- Ying et al. 2005 -RRB-	53158
@NP	synaptic plasticity	53158
@NP	Ying et al. 2005	53179
@NP	Ying	53179
@NP	et al. 2005	53184
@NP	et al.	53184
@NP	2005	53191
@NP	a permissive cellular environment	53210
@NP	axonal growth -LRB- Ghiani et al. 2007 -RRB- following SCI	53248
@NP	axonal growth -LRB- Ghiani et al. 2007 -RRB-	53248
@NP	axonal growth	53248
@NP	Ghiani et al. 2007	53263
@NP	Ghiani	53263
@NP	et al. 2007	53270
@NP	et al.	53270
@NP	2007	53277
@NP	SCI	53293
@NP	these tasks	53314
@NP	exercise mimics and possibly	53327
@NP	exercise	53327
@NP	mimics	53336
@NP	the effects of OEG transplants	53368
@NP	the effects	53368
@NP	OEG transplants	53383
@NP	neuronal regeneration and synaptic plasticity	53402
@NP	neuronal regeneration	53402
@NP	synaptic plasticity	53428
@NP	the first 3 months post-surgery	53456
@NP	the first 3 months	53456
@NP	the rats of this study	53488
@NP	the rats	53488
@NP	this study	53500
@NP	tomove	53524
@NP	an open field every day	53541
@NP	an open field	53541
@NP	every day	53555
@NP	inclined grids	53595
@NP	slopes from 45 to 90 deg	53613
@NP	slopes	53613
@NP	45 to 90 deg	53625
@NP	them	53646
@NP	the climbing test -LRB- Ramon-Cueto et al. 2000 -RRB-	53665
@NP	the climbing test	53665
@NP	Ramon-Cueto et al. 2000	53684
@NP	Ramon-Cueto	53684
@NP	et al. 2000	53696
@NP	et al.	53696
@NP	2000	53703
@NP	neurotrophic factor levelswere	53719
@NP	it	53764
@NP	that for some of them	53791
@NP	that	53791
@NP	some of them	53800
@NP	some	53800
@NP	them	53808
@NP	e.g.	53814
@NP	BDNF , NF-3 , HSP70 -RRB- and interaction of OEG and exercise	53819
@NP	BDNF , NF-3 , HSP70 -RRB-	53819
@NP	BDNF	53819
@NP	NF-3	53825
@NP	HSP70	53831
@NP	interaction of OEG and exercise	53842
@NP	interaction	53842
@NP	OEG and exercise	53857
@NP	the necessary amounts for tropisms	53888
@NP	the necessary amounts	53888
@NP	tropisms	53914
@NP	adaptive changes in central patterngenerator.OEGtransplants	53943
@NP	adaptive changes	53943
@NP	central patterngenerator.OEGtransplants	53963
@NP	concertwith exercise	54007
@NP	a sequence	54043
@NP	reciprocal cause and effect	54057
@NP	relative maintenance	54096
@NP	skeletal muscle properties	54120
@NP	the functional recovery previously noticed in the rats of this study	54167
@NP	the functional recovery	54167
@NP	the rats of this study	54213
@NP	the rats	54213
@NP	this study	54225
@NP	the absence of authentic regeneration of descending cortical pathways	54240
@NP	the absence	54240
@NP	authentic regeneration of descending cortical pathways	54255
@NP	authentic regeneration	54255
@NP	descending cortical pathways	54281
@NP	The variety of skeletal muscle phenotypes	54311
@NP	The variety	54311
@NP	skeletal muscle phenotypes	54326
@NP	OEG-transplanted paraplegic rats	54365
@NP	non-transplanted	54416
@NP	adaptive singularities of the spinal circuitry	54451
@NP	adaptive singularities	54451
@NP	the spinal circuitry	54477
@NP	different levels of activation of motor neurons	54510
@NP	different levels	54510
@NP	activation of motor neurons	54530
@NP	activation	54530
@NP	motor neurons	54544
@NP	The migratory behaviour and ability to produce neurotrophins of OEGs	54559
@NP	The migratory behaviour and ability	54559
@NP	neurotrophins of OEGs	54606
@NP	neurotrophins	54606
@NP	OEGs	54623
@NP	concert with the neurotrophic and synaptogenesic effects of exercise	54632
@NP	concert	54632
@NP	the neurotrophic and synaptogenesic effects of exercise	54645
@NP	the neurotrophic and synaptogenesic effects	54645
@NP	exercise	54692
@NP	some clues	54710
@NP	neuromuscular activity and muscle use	54737
@NP	neuromuscular activity	54737
@NP	muscle use	54764
@NP	OEG-transplanted rats	54793
@NP	turn	54819
@NP	an increased neuromuscular activity	54825
@NP	the formation and maintenance	54886
@NP	synaptic sites -LRB- Czeh et al. 1978 ; Landmesser , 1992 -RRB-	54919
@NP	synaptic sites	54919
@NP	Czeh et al. 1978 ; Landmesser , 1992	54935
@NP	Czeh	54935
@NP	et al. 1978 ; Landmesser , 1992	54940
@NP	et al. 1978	54940
@NP	et al.	54940
@NP	1978	54947
@NP	Landmesser , 1992	54953
@NP	Landmesser	54953
@NP	1992	54965
@NP	skeletal muscle protein expression -LRB- Talmadge , 2000 -RRB-	54984
@NP	skeletal muscle protein expression	54984
@NP	Talmadge , 2000	55020
@NP	Talmadge	55020
@NP	2000	55030
@NP	mass -LRB- Goldspink , 1999 ; Favier et al. 2008 -RRB-	55040
@NP	mass	55040
@NP	Goldspink , 1999 ; Favier et al. 2008	55046
@NP	Goldspink , 1999 ; Favier et al.	55046
@NP	Goldspink , 1999	55046
@NP	Goldspink	55046
@NP	1999	55057
@NP	Favier et al.	55063
@NP	Favier	55063
@NP	et al.	55070
@NP	2008	55077
@NP	this context	55087
@NP	the skeletalmuscle of OEG-transplanted animals	55101
@NP	the skeletalmuscle	55101
@NP	OEG-transplanted animals	55123
@NP	an additional opportunity	55156
@NP	differential gene expression	55194
@NP	the molecular mechanisms	55244
@NP	relative maintenance of skeletal muscle mass and protein expression patterns	55280
@NP	relative maintenance	55280
@NP	skeletal muscle mass and protein expression patterns	55304
@NP	Satellite	55358
@NP	cell activation and apoptosis , positive -LRB- e.g.	55368
@NP	cell activation and apoptosis	55368
@NP	e.g.	55409
@NP	IGF-1 and MGF -RRB- or negative -LRB- e.g.	55414
@NP	IGF-1 and MGF -RRB- or negative -LRB-	55414
@NP	IGF-1 and MGF -RRB-	55414
@NP	IGF-1	55414
@NP	MGF	55424
@NP	negative -LRB-	55432
@NP	e.g.	55442
@NP	IL-6 and myostatin -RRB- regulatory muscle growth factors	55447
@NP	IL-6 and myostatin -RRB- regulatory muscle	55447
@NP	growth factors	55485
@NP	myogenic regulatory factors -LRB- MRFs -RRB-	55501
@NP	myogenic regulatory factors	55501
@NP	MRFs	55530
@NP	other transcription factors	55540
@NP	skeletal muscle remodelling	55591
@NP	e.g. calcineurin-sensitive transcription factors NF-AT and MEF2	55620
@NP	e.g.	55620
@NP	calcineurin-sensitive transcription factors NF-AT and MEF2	55625
@NP	calcineurin-sensitive transcription factors	55625
@NP	NF-AT and MEF2	55669
@NP	miRNAs and other translation regulatory factors	55686
@NP	miRNAs and other translation	55686
@NP	regulatory factors	55715
@NP	molecules and signal transduction protein kinases	55758
@NP	e.g.	55809
@NP	Akt , ERK 1/2 -RRB-	55814
@NP	Akt	55814
@NP	ERK	55819
@NP	1/2	55823
@NP	Goldspink , 1999	55833
@NP	Goldspink	55833
@NP	1999	55844
@NP	Talmadge , 2000	55850
@NP	Talmadge	55850
@NP	2000	55860
@NP	Baldwin & Haddad , 2001	55866
@NP	Baldwin & Haddad	55866
@NP	2001	55884
@NP	Spangenburg & Booth , 2003	55890
@NP	Spangenburg & Booth	55890
@NP	2003	55911
@NP	Koulmann & Bigard , 2006	55917
@NP	Koulmann & Bigard	55917
@NP	2006	55936
@NP	Frost & Lang , 2007	55942
@NP	Frost & Lang	55942
@NP	2007	55956
@NP	Favier et al. 2008	55962
@NP	Favier	55962
@NP	et al.	55969
@NP	2008	55976
@NP	a review	55985
@NP	some	55999
@NP	the events , molecules and pathways	56007
@NP	OEG transplants in concert with exercise	56051
@NP	OEG transplants	56051
@NP	concert with exercise	56070
@NP	concert	56070
@NP	exercise	56083
@NP	the skeletal muscle phenotype	56116
@NP	the slow-to-fast transformation of myosin subunit isoforms	56708
@NP	the slow-to-fast transformation	56708
@NP	myosin subunit isoforms	56743
@NP	an increased activity	56785
@NP	glycolysis -LRB- Talmadge , 2000 ; Otis et al. 2004 -RRB-	56810
@NP	glycolysis	56810
@NP	Talmadge , 2000 ; Otis et al. 2004	56822
@NP	Talmadge , 2000 ; Otis et al.	56822
@NP	Talmadge , 2000	56822
@NP	Talmadge	56822
@NP	2000	56832
@NP	Otis et al.	56838
@NP	Otis	56838
@NP	et al.	56843
@NP	2004	56850
@NP	the EDL muscle	56860
@NP	type IIA , IID/X and IIB fibres ,	56886
@NP	type IIA	56886
@NP	IID/X and IIB fibres	56896
@NP	approximately the same proportion	56921
@NP	fibre type switching	56957
@NP	a narrower range of change	56982
@NP	a narrower range	56982
@NP	change	57002
@NP	a slow-to-fast transition	57016
@NP	EDL	57057
@NP	phenotypic changes in response	57095
@NP	phenotypic changes	57095
@NP	response	57117
@NP	reduced neuromuscular activity than the SOL	57129
@NP	reduced neuromuscular activity	57129
@NP	the SOL	57165
@NP	some markers of the EDL	57205
@NP	some markers	57205
@NP	the EDL	57221
@NP	the extent	57266
@NP	a particular muscle	57282
@NP	normality asSOLmarkers -LRB- i.e.GPDHactivity , Fig. 2 -RRB-	57313
@NP	normality asSOLmarkers	57313
@NP	i.e.GPDHactivity	57337
@NP	Fig. 2	57355
@NP	this conclusion	57391
@NP	agreement with observations -LRB- Borisov et al. 2001 -RRB-	57413
@NP	agreement	57413
@NP	observations -LRB- Borisov et al. 2001 -RRB-	57428
@NP	observations	57428
@NP	Borisov	57442
@NP	et al. 2001	57450
@NP	et al.	57450
@NP	2001	57457
@NP	fast-twitch fibres	57479
@NP	partial dedifferentiation	57532
@NP	slow-twitch fibres	57563
@NP	they	57591
@NP	higher phenotypic plasticity	57604
@NP	muscle mass and contractility	57640
@NP	muscle mass	57640
@NP	contractility	57656
@NP	a combination	57700
@NP	morphological and molecular markers of both slow and fast skeletal muscle	57717
@NP	morphological and molecular markers	57717
@NP	both slow and fast skeletal muscle	57756
@NP	this investigation	57803
@NP	depiction of a precise figure of the actual skeletal muscle phenotype	57831
@NP	depiction	57831
@NP	a precise figure of the actual skeletal muscle phenotype	57844
@NP	a precise figure	57844
@NP	the actual skeletal muscle phenotype	57864
@NP	the amplitude	57908
@NP	the change	57925
@NP	SCT	57947
@NP	a criteria	57954
@NP	the degree	57966
@NP	maintenance	57980
@NP	normal muscle characteristics	57995
@NP	OEG transplantation	58035
@NP	the coefficient	58056
@NP	correlation with behaviourally	58075
@NP	correlation	58075
@NP	motor functional capacity and the gradation of their expression levels	58113
@NP	motor functional capacity	58113
@NP	the gradation of their expression levels	58143
@NP	the gradation	58143
@NP	their expression levels	58160
@NP	animalswith similarmotor functional capacity	58187
@NP	we	58232
@NP	the histochemically assessed GPDH activity	58244
@NP	a sensitive phenotypic marker for bothSOLandEDLmuscle -LRB- see Fig. 2 -RRB-	58290
@NP	a sensitive phenotypic marker	58290
@NP	bothSOLandEDLmuscle	58324
@NP	Fig. 2	58349
@NP	The fraction of the less acidic variant -LRB- 2s -RRB- of the slowrMLCisoform	58358
@NP	The fraction	58358
@NP	the less acidic variant -LRB- 2s -RRB- of the slowrMLCisoform	58374
@NP	the less acidic variant -LRB- 2s -RRB-	58374
@NP	the less acidic variant	58374
@NP	2s	58399
@NP	the slowrMLCisoform	58406
@NP	Fig. 4 and Gonzalez et al. 2002	58430
@NP	Fig. 4	58430
@NP	Gonzalez et al. 2002	58441
@NP	Gonzalez	58441
@NP	et al.	58450
@NP	2002	58457
@NP	the SOL	58467
@NP	andmusclewetweight -LRB- ormuscle-somatic index , Fig. 1 -RRB- in the EDL	58476
@NP	andmusclewetweight -LRB- ormuscle-somatic index , Fig. 1 -RRB-	58476
@NP	andmusclewetweight	58476
@NP	ormuscle-somatic index	58496
@NP	Fig. 1	58520
@NP	the EDL	58531
@NP	additional sensitive and potentially useful markers	58544
@NP	muscle phenotype	58606
@NP	SDH activity	58624
@NP	SCT animals	58661
@NP	a lower proportion of type I and a higher proportion of type IIB fibres	58673
@NP	a lower proportion of type I	58673
@NP	a lower proportion	58673
@NP	type I	58695
@NP	a higher proportion of type IIB fibres	58706
@NP	a higher proportion	58706
@NP	type IIB fibres	58729
@NP	lower muscle oxidative capacity	58767
@NP	lower muscle	58767
@NP	oxidative capacity	58780
@NP	increased proportions	58831
@NP	IIA and IIX/D fibres	58856
@NP	the oxidative capacity -LRB- see Fig. 2 -RRB-	58901
@NP	the oxidative capacity	58901
@NP	Fig. 2	58929
@NP	Practically all parameters assessed in SOL or EDL muscles	58938
@NP	Practically all parameters	58938
@NP	SOL or EDL muscles	58977
@NP	a good correlation between muscle phenotype	59017
@NP	a good correlation	59017
@NP	muscle phenotype	59044
@NP	functional capacity	59086
@NP	they	59141
@NP	the degree	59193
@NP	a particular skeletal muscle	59209
@NP	normality	59249
@NP	muscles	59273
@NP	animals with similar functional capacity	59286
@NP	animals	59286
@NP	similar functional capacity	59299
@NP	The fraction	59328
@NP	the less acidic	59344
@NP	the variants -LRB- variant 2s -RRB- of the slow rMLC isoform in the SOL	59363
@NP	the variants -LRB- variant 2s -RRB-	59363
@NP	the variants	59363
@NP	variant 2s	59377
@NP	the slow rMLC isoform in the SOL	59392
@NP	the slow rMLC isoform	59392
@NP	the SOL	59417
@NP	the muscle-somatic index	59426
@NP	the EDL and the histochemical GPDH activity	59454
@NP	the EDL	59454
@NP	the histochemical GPDH activity	59466
@NP	muscles	59506
@NP	the exceptions	59529
@NP	The observation	59545
@NP	variant 2s of the slow rMLC	59566
@NP	variant 2s	59566
@NP	the slow rMLC	59580
@NP	OEG-transplanted animals	59611
@NP	levels statistically non-different	59639
@NP	levels	59639
@NP	controls	59679
@NP	the notion	59697
@NP	it	59713
@NP	a sensitive marker of phenotypic changes	59719
@NP	a sensitive marker	59719
@NP	phenotypic changes	59741
@NP	This conclusion	59761
@NP	agreement	59783
@NP	previous observations	59798
@NP	a model of indirect low-frequency	59828
@NP	a model	59828
@NP	indirect low-frequency	59839
@NP	chronic electrical stimulation	59862
@NP	fast-twitch muscle -LRB- Gonzalez et al. 2002 -RRB-	59896
@NP	fast-twitch muscle	59896
@NP	Gonzalez	59916
@NP	et al. 2002	59925
@NP	et al.	59925
@NP	2002	59932
@NP	changes in the proportion of this variant	59954
@NP	changes	59954
@NP	the proportion of this variant	59965
@NP	the proportion	59965
@NP	this variant	59983
@NP	any rearrangement of the sarcomere in the fast-to-slow direction	60004
@NP	any rearrangement	60004
@NP	the sarcomere in the fast-to-slow direction	60025
@NP	the sarcomere	60025
@NP	the fast-to-slow direction	60042
@NP	conclusion	60073
@NP	the results reported in this paper	60085
@NP	the results	60085
@NP	this paper	60109
@NP	evidence	60128
@NP	8 months	60142
@NP	a complete mid-thoracic SCT and simultaneous OEG transplantation	60156
@NP	the mean phenotypes of fast - and slow-twitch hind limb	60222
@NP	the mean phenotypes	60222
@NP	fast - and slow-twitch hind limb	60245
@NP	skeletal muscles	60277
@NP	those of non-transplanted rats	60313
@NP	those	60313
@NP	non-transplanted rats	60322
@NP	maintenance of skeletalmuscle properties	60356
@NP	maintenance	60356
@NP	skeletalmuscle properties	60371
@NP	the extent	60407
@NP	muscle phenotypes of OEG-transplanted animals	60427
@NP	muscle phenotypes	60427
@NP	OEG-transplanted animals	60448
@NP	normality	60484
@NP	animal	60516
@NP	animal	60526
@NP	substantive in a few cases	60539
@NP	substantive	60539
@NP	a few cases	60554
@NP	marginal in others	60569
@NP	marginal	60569
@NP	others	60581
@NP	sensory-motor functional capacity previously assessed in the same rats	60606
@NP	sensory-motor functional capacity	60606
@NP	the same rats	60663
@NP	The histochemical glycerol-3-phosphate dehydrogenase activity	60678
@NP	SOL and EDL muscle	60743
@NP	SOL	60743
@NP	EDL muscle	60751
@NP	the fraction	60766
@NP	the less acidic variant -LRB- variant 2s -RRB- of the slow rMLC isoform in SOL	60782
@NP	the less acidic variant -LRB- variant 2s -RRB-	60782
@NP	the less acidic variant	60782
@NP	variant 2s	60807
@NP	the slow rMLC isoform in SOL	60822
@NP	the slow rMLC isoform	60822
@NP	SOL	60847
@NP	muscle weight -LRB- or muscle-somatic index -RRB- in the EDL	60855
@NP	muscle weight -LRB- or muscle-somatic index -RRB-	60855
@NP	muscle weight	60855
@NP	the EDL	60898
@NP	sight	60916
@NP	the most sensitive phenotypic marker	60925
@NP	the degree	60974
@NP	a skeletal muscle approaches	60990
@NP	normal characteristics following SCT and OEG transplantation	61019
@NP	normal characteristics	61019
@NP	SCT and OEG transplantation	61052
@NP	The relatively low proportion	61081
@NP	animals	61114
@NP	8 months after OEG transplantation	61127
@NP	8 months	61127
@NP	OEG transplantation	61141
@NP	patterns of fibre	61168
@NP	patterns	61168
@NP	fibre	61180
@NP	type-specific protein expression close to normality	61186
@NP	type-specific protein expression close	61186
@NP	normality	61228
@NP	OEG transplants	61253
@NP	a consistent	61304
@NP	long-termmaintenance of normal skeletal muscle characteristics	61333
@NP	long-termmaintenance	61333
@NP	normal skeletal muscle characteristics	61357
@NP	A productive interaction with exercise	61397
@NP	A productive interaction	61397
@NP	exercise	61427
@NP	a possible mechanism	61452
@NP	OEG-mediated effects	61484
@NP	maintenance of skeletal muscle characteristics	61508
@NP	maintenance	61508
@NP	skeletal muscle characteristics	61523
@NP	Further work	61556
@NP	the molecular events	61596
@NP	OEG and exercise-derived signals	61650
@NP	skeletal muscle phenotypic changes	61688
@NP	skeletal muscle	61688
@NP	phenotypic changes	61704
@VP	to promote axonal regeneration	876
@VP	promote axonal regeneration	879
@VP	to restore sensory-motor function in animals with SCI	911
@VP	restore sensory-motor function in animals with SCI	914
@VP	could attenuate skeletal muscle phenotypic deterioration	1003
@VP	attenuate skeletal muscle phenotypic deterioration	1009
@VP	could underlie the functional recovery observed in behavioural tests	1081
@VP	underlie the functional recovery observed in behavioural tests	1087
@VP	observed in behavioural tests	1120
@VP	transected -LRB- SCT -RRB-	1300
@VP	encompassing all the parameters	1485
@VP	< 0.0001	1955
@VP	< 0.0001	2055
@VP	to overcome fibre type switching and to support a consistent	2236
@VP	to overcome fibre type switching	2236
@VP	overcome fibre type switching	2239
@VP	to support a consistent	2273
@VP	support a consistent	2276
@VP	generalized long-term maintenance of normal skeletal muscle characteristics	2301
@VP	underlying OEG transplantation effects on paralysed skeletal muscle	2467
@VP	paralysed skeletal muscle	2509
@VP	disrupts long spinal pathways and disconnects target organs from the brain	2571
@VP	target organs from the brain	2617
@VP	to regenerate their axons spontaneously in the mature CNS milieu	2673
@VP	regenerate their axons spontaneously in the mature CNS milieu	2676
@VP	resulting from a switch in gene expression programs	3082
@VP	governing the isoforms of the myosin subunits	3154
@VP	has also been noticed -LRB- Talmadge , 2000 ; Otis et al. 2004 -RRB-	4127
@VP	been noticed -LRB- Talmadge , 2000 ; Otis et al. 2004 -RRB-	4136
@VP	noticed -LRB- Talmadge , 2000 ; Otis et al. 2004 -RRB-	4141
@VP	paralysed skeletal muscle -LRB- Talmadge , 2000 -RRB-	4472
@VP	leading to faster	4924
@VP	increasing the level of electrical activation or the load bearing , or both ,	5064
@VP	opposing the effect of SCI	5216
@VP	increase neuromuscular activity	5748
@VP	see Pette & Staron , 1997 for a review	5979
@VP	to evoke motor automatism	6434
@VP	evoke motor automatism	6437
@VP	to stimulate stepping -LRB- Wernig et al. 1999 ; Kjaer , 2000 -RRB-	6464
@VP	stimulate stepping -LRB- Wernig et al. 1999 ; Kjaer , 2000 -RRB-	6467
@VP	stepping -LRB- Wernig et al. 1999 ; Kjaer , 2000 -RRB-	6477
@VP	induced by electrical stimulation	6638
@VP	induced by SCI	6735
@VP	functional descending upper motor neuron pathways in SCI individuals	6919
@VP	would enable skeletal muscle protein expression pattern	6989
@VP	enable skeletal muscle protein expression pattern	6995
@VP	paralysed muscles towards normal	7045
@VP	to promote an effective regeneration of the injured spinal cord	7139
@VP	promote an effective regeneration of the injured spinal cord	7142
@VP	to preserve normal contractile properties and to favour functional recovery	7837
@VP	to preserve normal contractile properties	7837
@VP	preserve normal contractile properties	7840
@VP	to favour functional recovery	7883
@VP	favour functional recovery	7886
@VP	transected spinal cords	8121
@VP	affected slow	8394
@VP	approached normal phenotype	8452
@VP	assess on a quantitative basis changes in the locomotor capacity of SCT animals	8607
@VP	were dissected from the heads under sterile conditions	9231
@VP	dissected from the heads under sterile conditions	9236
@VP	incubated for 10 min at 37 ◦ C with 0.25 % trypsin -LRB- w/v , Sigma -RRB-	9420
@VP	supplemented with 10 % fetal bovine serum , 100 Uml − 1 penicillin	9665
@VP	washing several times with D/F -10 S and centrifuging	9764
@VP	were dissociated in 1 ml D/F -10 S using a fire-polished Pasteur pipette	9823
@VP	dissociated in 1 ml D/F -10 S using a fire-polished Pasteur pipette	9828
@VP	using a fire-polished Pasteur pipette	9855
@VP	cultured in D/F -10 S at 37 ◦ C and 5 % CO2	10028
@VP	was changed every 2 -- 3 days	10083
@VP	changed every 2 -- 3 days	10087
@VP	plating	10128
@VP	using 0.1 % trypsin -LRB- w/v -RRB- in Ca2 +	10173
@VP	kindly provided by Dr Patrick Wood , Miami Project to Cure Paralysis	10335
@VP	to Cure Paralysis	10385
@VP	Cure Paralysis	10388
@VP	described	10419
@VP	containing mouse anti-p75	10644
@VP	washed with DMEM	10697
@VP	detached from culture flasks	10721
@VP	were seeded	10750
@VP	seeded	10755
@VP	were discarded	10842
@VP	discarded	10847
@VP	Bound	10858
@VP	were detached from the dishes with a cell scraper	10870
@VP	detached from the dishes with a cell scraper	10875
@VP	seeded onto poly	10924
@VP	were cultured in D/F -10 S for no more than 2 weeks to avoid senescence	11004
@VP	cultured in D/F -10 S for no more than 2 weeks to avoid senescence	11009
@VP	to avoid senescence	11054
@VP	avoid senescence	11057
@VP	were added to the culture medium	11191
@VP	added to the culture medium	11196
@VP	maintained during the whole culture period	11246
@VP	was changed every 2 -- 3 days	11297
@VP	changed every 2 -- 3 days	11301
@VP	detached from the flasks	11488
@VP	labelled with bisbenzimide -LRB- Hoechst 33342 ; Sigma -RRB-	11514
@VP	re-suspended in DMEM at a density of 105 cells	11568
@VP	μl −	11615
@VP	described in this paper	11726
@VP	served as experimental animals in a previous study	11800
@VP	concerning tissue culture	11903
@VP	have been described in detail therein	12030
@VP	been described in detail therein	12035
@VP	described in detail therein	12040
@VP	purified as reported previously	12310
@VP	reported previously	12322
@VP	plating the primary cultures	12403
@VP	detached from the flasks	12483
@VP	labelled with a nuclear fluorochrome , re-suspended in culture medium	12509
@VP	used for transplantation	12582
@VP	after pin prick/dull stimulation of the wrist and ankle joints , respectively	12957
@VP	to expose thoracic segments 8 and 9 -LRB- T8 -- T9 -RRB-	13092
@VP	expose thoracic segments 8 and 9 -LRB- T8 -- T9 -RRB-	13095
@VP	was opened	13157
@VP	opened	13161
@VP	exposed and sectioned with microscissors	13189
@VP	were lifted to ensure completeness of the lesion	13242
@VP	lifted to ensure completeness of the lesion	13247
@VP	to ensure completeness of the lesion	13254
@VP	ensure completeness of the lesion	13257
@VP	described	13527
@VP	containing 50 000 cells -LRB- 200 000 per stump -RRB-	13612
@VP	transected	13669
@VP	injected with 0.5 μl of medium devoid of cells in the same spinal cord locations	13724
@VP	were sham operated -LRB- C , control un-injured group , n = 8 -RRB-	13817
@VP	operated -LRB- C , control un-injured group , n = 8 -RRB-	13827
@VP	were performed	13918
@VP	performed	13923
@VP	was covered with gelfoam	13950
@VP	covered with gelfoam	13954
@VP	were sutured	13997
@VP	sutured	14002
@VP	were kept on a heating pad until they were completely awake	14058
@VP	kept on a heating pad until they were completely awake	14063
@VP	were completely awake	14096
@VP	was administered at that time and twice more every 8 h.	14354
@VP	administered at that time and twice more every 8 h.	14358
@VP	todiminish the risk of infections	14613
@VP	occurred during the post-surgery period	14800
@VP	were left to move	15200
@VP	left to move	15205
@VP	to move	15210
@VP	move	15213
@VP	try moving	15222
@VP	moving	15226
@VP	an open field every day for 20 min	15244
@VP	was analysed in all rats -LRB- Ramon-Cueto et al. 2000 -RRB-	15463
@VP	analysed in all rats -LRB- Ramon-Cueto et al. 2000 -RRB-	15467
@VP	allowed discerning between local reflex activity and real voluntary movement	15604
@VP	calculated on an individual basis	15775
@VP	to maintain body weight steady in a range of 270	15810
@VP	maintain body weight steady in a range of 270	15813
@VP	were allowed to eat ad libitum until killing	15892
@VP	allowed to eat ad libitum until killing	15897
@VP	to eat ad libitum until killing	15905
@VP	eat ad libitum until killing	15908
@VP	described above	16311
@VP	described above	16456
@VP	were dissected quickly	16553
@VP	dissected quickly	16558
@VP	dissected for histological analysis , as previously reported	16694
@VP	reported	16745
@VP	directing animal welfare -LRB- Real Decreto 223/88 , BOE of 18 ofMarch -RRB-	16964
@VP	adhered to the recommendations	17034
@VP	were weighed and anaesthetized as indicated earlier in this section	17388
@VP	weighed and anaesthetized as indicated earlier in this section	17393
@VP	indicated earlier in this section	17422
@VP	were dissected quickly	17496
@VP	dissected quickly	17501
@VP	Individualmuscleswereweighed	17520
@VP	were prepared from the muscle belly in isopentane chilled with liquid nitrogen	17564
@VP	prepared from the muscle belly in isopentane chilled with liquid nitrogen	17569
@VP	chilled with liquid nitrogen	17614
@VP	stored at − 70 ◦ C until analysed	17647
@VP	analysed	17669
@VP	prepared at − 20 ◦ C	17710
@VP	cover slips	17814
@VP	slips	17820
@VP	was frozen in liquid nitrogen	17904
@VP	frozen in liquid nitrogen	17908
@VP	maintained at − 70 ◦ C until used for electrophoresis	17938
@VP	used for electrophoresis	17964
@VP	was performed on 10μm thick serial cryostat cross-sections	18127
@VP	performed on 10μm thick serial cryostat cross-sections	18131
@VP	described by Rivero et al. -LRB- 1999 -RRB-	18307
@VP	was controlled in additional serial sections incubated without primary antibody	18906
@VP	controlled in additional serial sections incubated without primary antibody	18910
@VP	incubated without primary antibody	18951
@VP	indicated in Table 1	19094
@VP	designated I , IIA , IID/X and IIB	19188
@VP	was observedwithin fast-twitchsubtypes -LRB- Delp & Duan ,1996 -RRB-	20030
@VP	containing substrate -LRB- either succinic acid or glycerol-3-phosphate -RRB-	20283
@VP	incubated in the absence of substrate	20367
@VP	were used to correct for non-specific staining	20406
@VP	used to correct for non-specific staining	20411
@VP	to correct for non-specific staining	20416
@VP	correct for non-specific staining	20419
@VP	performed in 10 μm thick sections following the procedure	20542
@VP	described by Blanco et al. -LRB- 1988 -RRB-	20611
@VP	determined on 14 μm thick sections according to Martin et al. -LRB- 1985 -RRB-	20715
@VP	see below	20883
@VP	are linear for at least 15 or 30 min	20925
@VP	allowed enzymatic activities to be expressed as steady-state rates	21022
@VP	to be expressed as steady-state rates	21051
@VP	be expressed as steady-state rates	21054
@VP	expressed as steady-state rates	21057
@VP	were expressed as optical density per time unit -LRB- OD min − 1 -RRB-	21107
@VP	expressed as optical density per time unit -LRB- OD min − 1 -RRB-	21112
@VP	containing between 125 and 175 fibres per muscle sample	21269
@VP	was selected for further analysis	21325
@VP	selected for further analysis	21329
@VP	were surveyed to find regions free of artefacts	21376
@VP	surveyed to find regions free of artefacts	21381
@VP	to find regions free of artefacts	21390
@VP	find regions free of artefacts	21393
@VP	visualized	21435
@VP	were systematically digitized	21843
@VP	systematically digitized	21848
@VP	numbered at random and classified with their immunohistochemical stains	21888
@VP	classified with their immunohistochemical stains	21911
@VP	counting the relative frequency of the various fibre types	22061
@VP	stained for quantitative SDH and GPDH	22160
@VP	was digitized as a grey level -LRB- range of grey level 0 -- 255 -RRB- image	22198
@VP	digitized as a grey level -LRB- range of grey level 0 -- 255 -RRB- image	22202
@VP	analysed	22279
@VP	was determined for each quantitative histochemical assay	22317
@VP	determined for each quantitative histochemical assay	22321
@VP	reported as OD min − 1	22385
@VP	analysed with substrate minus the mean of the two tissue blank sections	22467
@VP	was used to calculate the enzyme activity of a single muscle sample	22539
@VP	used to calculate the enzyme activity of a single muscle sample	22543
@VP	to calculate the enzyme activity of a single muscle sample	22548
@VP	calculate the enzyme activity of a single muscle sample	22551
@VP	can influence the reliability of histochemical enzymeactivity determination	22634
@VP	influence the reliability of histochemical enzymeactivity determination	22638
@VP	was always below 5 %	23023
@VP	previously described	23205
@VP	were averaged according with each muscle biopsy specimen	23237
@VP	averaged according with each muscle biopsy specimen	23242
@VP	has no negative impact onmuscle fibre size -LRB- Snow & Guy , 1980 -RRB-	23383
@VP	were performed essentially as previously described	23673
@VP	performed essentially as previously described	23678
@VP	described	23714
@VP	focusing	23824
@VP	to determine the relative proportions of MLC isoforms	24019
@VP	determine the relative proportions of MLC isoforms	24022
@VP	were analysed as previously reported -LRB- Gonzalez et al. 2002 -RRB-	24230
@VP	analysed as previously reported -LRB- Gonzalez et al. 2002 -RRB-	24235
@VP	reported -LRB- Gonzalez et al. 2002 -RRB-	24258
@VP	stained gels	24321
@VP	were performed in the linear absorption range	24451
@VP	performed in the linear absorption range	24456
@VP	were expressed as means ± s.d.	24553
@VP	expressed as means ± s.d.	24558
@VP	± s.d.	24576
@VP	using the statistical program SPSS 8.0	24661
@VP	was established	24719
@VP	established	24723
@VP	was accepted -LRB- Levene statistics -RRB-	24840
@VP	accepted -LRB- Levene statistics -RRB-	24844
@VP	was discarded	24931
@VP	discarded	24935
@VP	were considered statistically significant at P < 0.05	24958
@VP	considered statistically significant at P < 0.05	24963
@VP	using the package Statistica for Windows	25268
@VP	grouping skeletalmuscles of experimental animals according to phenotype	25332
@VP	to establish their homology	25459
@VP	establish their homology	25462
@VP	to classify individual muscles into one group or the other	25491
@VP	classify individual muscles into one group or the other	25494
@VP	are indicated in Fig. 5 for each group pair	25975
@VP	indicated in Fig. 5 for each group pair	25979
@VP	expressed in skeletal muscle fibres Figure 1	26188
@VP	are	26772
@VP	means ± S.D. of the number of animals per group indicated above	26776
@VP	indicated above	26824
@VP	were considered independently	26863
@VP	considered independently	26868
@VP	was twice the number of animals per group	26916
@VP	indicated in the Methods section	27360
@VP	stained for GPDH -LRB- soleus -RRB- or SDH -LRB- EDL -RRB-	27709
@VP	are	27859
@VP	corresponding to 2-fold number of samples -LRB- both hind limbs -RRB- per group	27928
@VP	situated in the control EDL muscle for SDH histochemistry	28134
@VP	indicates 1 μm	28193
@VP	induced by a complete transversal section of the spinal cord	28280
@VP	was performed in serial cross-sections	28411
@VP	performed in serial cross-sections	28415
@VP	correlated to those shown in Fig.	28450
@VP	shown in Fig.	28470
@VP	directed against different myosin heavy chain -LRB- MHC -RRB- isoforms	28531
@VP	stained for myofibrillar ATPase with pre-incubations at pH 4.45 or 10.45	28595
@VP	indicated in the Methods section	28672
@VP	recognizes MHC-I	28737
@VP	denotes three staining intensities	28845
@VP	represent good and bad recovery , respectively	29358
@VP	expressing only one MHC isoform	29460
@VP	expressing two MHC isoforms	29505
@VP	are	29568
@VP	were considered independently	29698
@VP	considered independently	29703
@VP	indicate 1 μm	29941
@VP	were identified as reported previously -LRB- Gonzalez et al. 2002 -RRB-	30583
@VP	identified as reported previously -LRB- Gonzalez et al. 2002 -RRB-	30588
@VP	reported previously -LRB- Gonzalez et al. 2002 -RRB-	30602
@VP	transplanted with OEGs -LRB- n = 9 -RRB-	30989
@VP	are	31571
@VP	indicated above , corresponding to twice the number of muscles	31623
@VP	corresponding to twice the number of muscles	31640
@VP	included the following variables : wet weight , muscle-somatic index	32193
@VP	was taken instead of types I and IIA	32653
@VP	taken instead of types I and IIA	32657
@VP	mentioned above	32804
@VP	are considered together	32820
@VP	considered together	32824
@VP	represent SCT rats	32853
@VP	numbered from best -LRB- 1 -RRB- to worst -LRB- 9 -RRB-	32915
@VP	Open	33033
@VP	filled symbols represent left and right hind limb muscles , respectively	33042
@VP	represent left and right hind limb muscles , respectively	33057
@VP	was passed , 8 months after the intervention for SCT and OEG transplantation	33721
@VP	passed , 8 months after the intervention for SCT and OEG transplantation	33725
@VP	, results from behavioural tests -LRB- contact placing , C ,	33799
@VP	, results	33799
@VP	results	33801
@VP	performed 3 , 5 and 7 months after the intervention , as	33887
@VP	reported previously -LRB- Ramon-Cueto et al. 2000 -RRB-	33942
@VP	left	34040
@VP	assessed by immunohistochemistry	34113
@VP	obtained from densitometry of Coomassie blue-stained 2D electrophoretograms	34206
@VP	obtained as in C.	34373
@VP	determined by quantitative histochemistry	34450
@VP	are means ± S.D. of all animals of the group	34602
@VP	means ± S.D. of all animals of the group	34606
@VP	ordered from best -LRB- 1 -RRB- to worst -LRB- 9 -RRB-	34775
@VP	A is a modification of Fig. 1 from the above-mentioned reference	34910
@VP	is a modification of	34912
@VP	assessed by means of behavioural tests	35056
@VP	are indicated together with the statistical significance of the observation	35096
@VP	indicated together with the statistical significance of the observation	35100
@VP	reduced to 56 % and 76 % of the control values , respectively -LRB- Fig. 1 -RRB-	35457
@VP	referred to bodyweight	35546
@VP	mainly formed by slow-twitch fibres with a higher diameter , more than the EDL	35728
@VP	formed essentially by fast-twitch fibres	35807
@VP	transplanted with OEG immediately after SCT	35860
@VP	did not reach statistical significance	36019
@VP	reach statistical significance	36027
@VP	increased in OEG-transplanted animals	36195
@VP	remaining higher -LRB- P < 0.0001 -RRB- than controls	36969
@VP	was capable of normalizing the glycolytic activity of the EDL to control values	37224
@VP	normalizing the glycolytic activity of the EDL to control values	37239
@VP	to control values	37286
@VP	control values	37289
@VP	measured by quantitative SDH histochemistry	37335
@VP	to increase in the soleus and decrease in the EDL of cordotomized animals	37387
@VP	increase in the soleus and decrease in the EDL of cordotomized animals	37390
@VP	increase in the soleus	37390
@VP	decrease in the EDL of cordotomized animals	37417
@VP	compared to controls but differences	37467
@VP	did not reach statistical significance -LRB- Fig. 2 -RRB-	37504
@VP	reach statistical significance -LRB- Fig. 2 -RRB-	37512
@VP	were statistically different from both	37721
@VP	induced a slow-to-fast fibre type switching in both muscle types	37970
@VP	is composed primarily of slow-twitch fibres	38050
@VP	composed primarily of slow-twitch fibres	38053
@VP	formed by fast-twitch fibres -LRB- Fig. 3 -RRB-	38155
@VP	increased	38375
@VP	had no significant effect on fibre type distribution in the EDL muscle	38431
@VP	tended to be lower	38538
@VP	to be lower	38545
@VP	be lower	38548
@VP	expressing MHC-I	38627
@VP	expressing MHC-IIA or IID/X	38682
@VP	increased -LRB- see Fig. 3 -RRB-	38742
@VP	see Fig. 3	38753
@VP	tended to be lower than in non-transplanted animals	38980
@VP	to be lower than in non-transplanted animals	38987
@VP	be lower than in non-transplanted animals	38990
@VP	was neither different from themnor fromcontrols	39036
@VP	is indicative of a high degree of variability in the individual responses	39212
@VP	tested	39323
@VP	were observed between contralateralmuscles	39357
@VP	observed between contralateralmuscles	39362
@VP	was lower -LRB- P < 0.05 -RRB- in left as compared with right hind limb muscles	39622
@VP	left as compared with right hind limb muscles	39645
@VP	was lower than in controls -LRB- Fig. 4a and b panels -RRB-	39935
@VP	denoted 2s in 2D patterns of Fig. 4	40113
@VP	was reduced to less than one fifth of control	40150
@VP	reduced to less than one fifth of control	40154
@VP	compared to non-transplanted animals	40376
@VP	did not reach statistical significance -LRB- Fig. 4a and b panels -RRB-	40429
@VP	reach statistical significance -LRB- Fig. 4a and b panels -RRB-	40437
@VP	previously described	40495
@VP	depicted in Fig. 4 , 2D patterns	40542
@VP	slow -LRB- s -RRB- rMLC isoforms displayed different variants	40594
@VP	was greatly lowered following cordotomy	40865
@VP	lowered following cordotomy	40877
@VP	was also reduced in SCT animals in a statistically significant manner	41020
@VP	reduced in SCT animals in a statistically significant manner	41029
@VP	restore/maintained the proportion of variant 2s in the EDL to the control level	41122
@VP	was statistically non-different from both control and non-transplanted animals	41301
@VP	further indicated a wide range of variation in the individual responses	41451
@VP	was included instead of that of type I and IIA	42406
@VP	included instead of that of type I and IIA	42410
@VP	left	42779
@VP	could be classified as originating from OEG-transplanted animals	42904
@VP	be classified as originating from OEG-transplanted animals	42910
@VP	originating from OEG-transplanted animals	42927
@VP	classified correctly , 4 as deriving from SCT and only 1 from control animals	43022
@VP	deriving from SCT and only 1 from control animals	43049
@VP	expected	43140
@VP	was still higher than in the SOL	43213
@VP	are indicated in Fig. 5	43349
@VP	indicated in Fig. 5	43353
@VP	situated between control and non-transplanted	43638
@VP	deduced from their relative Mahalanobis distances	43770
@VP	measured in this investigation for SOL	44114
@VP	correlated very well with previously published data	44168
@VP	graded from 0 to 4 as previously described in Ramon-Cueto et al. 2000	44276
@VP	previously described in Ramon-Cueto et al. 2000	44298
@VP	mean values of these parameters in control -LRB- C -RRB-	45662
@VP	paralysed -LRB- SCT -RRB-	45713
@VP	ordered from 1 to 9 according to previously reported time	45867
@VP	represented in Fig. 6A	46012
@VP	showed the first signs of recovery at the final part of the 8 month period	46258
@VP	considered	46647
@VP	to be graded according to expression of a molecular marker	46845
@VP	be graded according to expression of a molecular marker	46848
@VP	graded according to expression of a molecular marker	46851
@VP	not shown	47168
@VP	< 0.0001	47248
@VP	< 0.0001	47314
@VP	showed the highest discriminatory potential	47349
@VP	derived from behavioural tests	47825
@VP	are generally intermediate between paralysed and control and different from both	48014
@VP	determined by means of behavioural tests	48308
@VP	tested	48371
@VP	approaches normal characteristics following SCT and OEG transplantation	48629
@VP	were the most sensitive markers in EDL muscle	48779
@VP	were different from those of non-transplanted and from controls	49371
@VP	obtained in this analysis	49513
@VP	approached normality	49803
@VP	was highly variable fromone animal tothe other	49824
@VP	was relatively high only in 3 out of 9 OEG-transplanted animals	49875
@VP	showed loss of sensory-motor function 3 months after the intervention	49986
@VP	showed muscle phenotypes closer to non-transplanted	50056
@VP	re-establishing a functional connectivity of local spinal circuits	50404
@VP	descending motor pathways	50475
@VP	used in this investigation -LRB- Ramon-Cueto et al. 2000 -RRB-	50546
@VP	was reported	50695
@VP	reported	50699
@VP	determined whether the regenerated axons established functional connections	50742
@VP	established functional connections	50783
@VP	were formed	50894
@VP	formed	50899
@VP	could get normal enough to support appropriate activity patterns to reoccur	50907
@VP	get normal enough to support appropriate activity patterns to reoccur	50913
@VP	to support appropriate activity patterns to reoccur	50931
@VP	support appropriate activity patterns to reoccur	50934
@VP	to reoccur	50972
@VP	reoccur	50975
@VP	leading to increased neuromuscular activity and motor automatism	51169
@VP	Descending upper motor neuron pathways in the motor cortex	51235
@VP	control the coordinated movements associated with locomotion	51376
@VP	associated with locomotion	51410
@VP	becomes the only input to control central pattern generation in SCI individuals	51530
@VP	to control central pattern generation in SCI individuals	51553
@VP	control central pattern generation in SCI individuals	51556
@VP	are utilized normally	51789
@VP	utilized normally	51793
@VP	could underlie the functional recovery observed in these animals	51855
@VP	underlie the functional recovery observed in these animals	51861
@VP	observed in these animals	51894
@VP	using OEG in regenerative studies of the SC	51939
@VP	counteract local inhibitory influences for axon growth	52008
@VP	re-establish glial pathways	52064
@VP	stimulate neuronal gene expression and axonal growth	52131
@VP	to secrete some of them in considerable amounts	52385
@VP	secrete some of them in considerable amounts	52388
@VP	to produce NT-4 in an activity-dependent manner	52670
@VP	produce NT-4 in an activity-dependent manner	52673
@VP	carrying out these tasks	53301
@VP	to make them familiar with the climbing test -LRB- Ramon-Cueto et al. 2000 -RRB-	53638
@VP	make them familiar with the climbing test -LRB- Ramon-Cueto et al. 2000 -RRB-	53641
@VP	not measured	53750
@VP	is reasonable to assume that for some of them -LRB- e.g.	53767
@VP	to assume that for some of them -LRB- e.g.	53781
@VP	assume that for some of them -LRB- e.g.	53784
@VP	underlie the functional recovery previously noticed in the rats of this study	54158
@VP	previously noticed in the rats of this study	54191
@VP	could arise from adaptive singularities of the spinal circuitry	54434
@VP	arise from adaptive singularities of the spinal circuitry	54440
@VP	leading to different levels of activation of motor neurons	54499
@VP	to produce neurotrophins of OEGs	54595
@VP	produce neurotrophins of OEGs	54598
@VP	could increase in OEG-transplanted rats	54775
@VP	increase in OEG-transplanted rats	54781
@VP	could indirectly affect the skeletal muscle phenotype	56092
@VP	affect the skeletal muscle phenotype	56109
@VP	expected	56698
@VP	formed by type IIA , IID/X and IIB fibres , in approximately the same proportion	56876
@VP	contrary to expected	57183
@VP	grading the extent	57258
@VP	approached normality asSOLmarkers -LRB- i.e.GPDHactivity , Fig. 2 -RRB-	57302
@VP	be even more susceptible to partial dedifferentiation than slow-twitch fibres	57504
@VP	possess higher phenotypic plasticity	57596
@VP	are controlled independently	57670
@VP	controlled independently	57674
@VP	used in this investigation	57795
@VP	allowed depiction of a precise figure of the actual skeletal muscle phenotype	57823
@VP	see Fig. 2	58345
@VP	see Fig. 4 and Gonzalez et al. 2002	58426
@VP	to assess muscle phenotype	58596
@VP	assess muscle phenotype	58599
@VP	both contributing to lower muscle oxidative capacity	58746
@VP	tended to increase the oxidative capacity -LRB- see Fig. 2 -RRB-	58882
@VP	to increase the oxidative capacity -LRB- see Fig. 2 -RRB-	58889
@VP	increase the oxidative capacity -LRB- see Fig. 2 -RRB-	58892
@VP	see Fig. 2	58925
@VP	assessed in SOL or EDL muscles	58965
@VP	establishing a good correlation between muscle phenotype	59004
@VP	tested functional capacity	59079
@VP	considered	59120
@VP	approached normality	59238
@VP	to compare muscles from animals with similar functional capacity	59262
@VP	compare muscles from animals with similar functional capacity	59265
@VP	were probably the exceptions	59515
@VP	supports the notion that it is a sensitive marker of phenotypic changes	59688
@VP	is a sensitive marker of phenotypic changes	59716
@VP	precede any rearrangement of the sarcomere in the fast-to-slow direction	59996
@VP	reported in this paper	60097
@VP	indicating maintenance of skeletalmuscle properties	60345
@VP	approached normality greatly	60473
@VP	previously assessed in the same rats	60640
@VP	showed patterns of fibre type-specific protein expression close to normality	61161
@VP	indicated that OEG transplants alone were insufficient to support a consistent	61238
@VP	were insufficient to support a consistent	61275
@VP	to support a consistent	61293
@VP	support a consistent	61296
@VP	generalized long-termmaintenance of normal skeletal muscle characteristics	61321
